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ABSTRACT
Classical epithelio-mesenchymal interactions are said to result in root development. These 
interactions may be regulated by a number of growth factors. Fibroblast growth factors 
(FGF’s), members of a highly conserved family of polypeptides, the heparin binding 
growth factors (HBGF’s) are known to play a crucial role during the development of certain 
vertebrate organs, including the tooth. Previously, FGF-2, 3, 4, and 8 have been shown to 
play a role in crown development. The aim of this study was therefore to elucidate the 
spatial and temporal expression of FGF-2 in the developing root. Parasagittal sections of 
the maxillary and mandibular arches of six age groups of post-natal mice (days 9, 10, 12, 
16, 20 and 24) were cut and the developing roots of the incisor and molar teeth identified. 
Immunocytochemistry utilizing anti-FGF-2 was performed on sections of teeth from all 
stages using the strept-avidin biotin technique. Appropriate positive, negative and 
absorption controls were performed to ensure the specificity of the antibody. FGF-2 was 
immunolocalized in the cytoplasm and nuclei of the odontoblasts, fibroblasts of the 
periodontal ligament and pulp chamber, as well as in the osteoblasts surrounding 
developing bone at all the stages examined. Intense staining for FGF-2 was observed in 
differentiating odontoblasts at the apical end and the furcation zone of the developing root. 
FGF-2 localization was also observed in the cytoplasm of the ameloblasts on days 9, 10 and 
12 and in cementoblasts on day 16, 20 and 24. The spatio-temporal expression pattern of 
FGF-2 in the developing mouse tooth root suggests that FGF-2 with other signaling 
molecules previously reported such as bone morphogenetic proteins-2, 3 and 7 (BMP-2, 3 
and 7) participate in the signaling network during the tooth root development.
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Chapter one-introduction
CHAPTER ONE
1.0 INTRODUCTION
1.1 Preamble
Signals that orchestrate the expression of genes in time and space are a central theme in 
developmental biology. This quest to understand these mechanisms has lead scientists to 
explore the process of organogenesis in mammals. Organogenesis, which is a complex 
paradigm, is the progression of a cell or a tissue through a series of events that finally lead 
to the formation of a well-defined structure, both in shape and form. To achieve this final 
outcome, every cell passes through three fundamental stages: firstly, availability of 
positional information and interpretation of this information to initiate organ formation at 
the correct place (induction); secondly formation of a rudiment organ by the cells 
(morphogenesis) and finally formation of an organ-specific structure (differentiation). 
Morphogenesis, which is a critical stage of this process, is governed by co-coordinated, 
sequential and often reciprocal cascades of events between the epithelium and mesenchyme 
(Grobstein, 1953; Saxen et al., 1976). Reciprocal inductions underlie the development of 
many organs such as the limbs, hair follicles, lungs, kidneys and teeth (Mina and Kollar, 
1987; Neubuser et al., 1997; Cancilla et al, 1999; Thesleff, 2000; Paria et al., 2001). 
Events which govern the process of morphogenesis may include cell proliferation, cell 
differentiation, cell migration, apoptosis [programmed cell death], positional signaling and 
matrix synthesis (Wolpert, 1989; Neubuser et ah, 1997; Hogan, 1999). This cascade of 
events, which are key features in the process of morphogenesis, may either be facilitated by 
spatial and temporal expression of conserved families of signaling molecules (Vainio et al.,
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1993; Peters and Balling, 1999; Thesleff, 2000), or as a result of permissive and instructive 
inductive interactions (Thesleff, 2000).
Tooth development also follows this pattern of morphogenesis and is believed to involve 
signals such as fibroblast growth factor (Wilkinson et al., 1989; Kettunen et al., 2000), 
bone morphogenetic proteins (Vaino et al., 1993; Thomadakis et al., 1999), hedgehog 
genes (Dassule et al., 2000 Gritli-Linde, 2002), Wnt genes (Sarkar and Sharpe, 1999; 
Jemvall and Thesleff, 2000; Sarkar et al., 2000), expression of transcription factors [e.g. 
Msx-1 and Msx-2] (Chen et al., 1996), the synthesis of membrane protein syndecan and 
extracellular protein tenascin (Tucker et al., 1993).
1.2 Morphogenesis and tooth development
Tooth development is a complex morphogenetic process that is guided both by intrinsic 
genetic information and epigenetic environmental signals. A characteristic feature of 
odontogenesis and dental cytodifferentiation in mammals is the interaction between the 
epithelium and mesenchyme both sequentially and reciprocally, at successive key 
morphogenetic stages (Chen et al., 1996; Thesleff and Sharpe, 1997; Jemvall and Thesleff, 
2000). In mammals, classical tissue recombination experiments have demonstrated that 
tooth morphogenesis involves an interaction between the oral epithelium of the first 
pharyngeal arch (E-9 to E- ll  in the mouse) covering the maxillary, median-nasal and 
mandibular processes and the underlying neural-crest derived ectomesenchymal cells 
(Kollar and Baird, 1970; Slavkin and Bringas, 1976; Mina and Kollar, 1987; Karanova et 
al., 1992; Vaino et al., 1993; Thomas et al., 1997; Choi et al., 2000). The neural crest cells 
subsequently signal reciprocally to the epithelium and regulate its morphogenesis. It is 
believed that the same conserved multigene signaling families mediate epithelio-
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mesenchymal interactions in tooth development as in other vertebrate organs (Jemvall and 
Thesleff, 2000).
In the past two decades, a number of genes and gene products have been discovered that are 
believed to be the chemical signals for cell-to-cell communications between the oral 
epithelium (dental lamina, enamel organ epithelia and inner enamel epithelium) and the 
ectomesenchymal cells of the dental papilla that are required for tooth formation 
(MacKenzie et al., 1992; Vainio et al., 1993; Chen et al., 1996; Neubuser et al., 1997; 
Bei and Maas, 1998; Kettunen and Thesleff, 1998). These chemical signals or 
morphoregulatory proteins are believed to play their role by accomplishing the following 
tasks. They:
(i) act directly on the deoxyribonucleic acid (DNA), present in the chromosomes in 
the nucleus of the somatic cells [e.g. transcription control molecules such as 
Msx-1, Msx-2, Lef-1 and Hox genes] (MacKenzie et al., 1992; Chen et al., 
1996; Thesleff and Sharpe, 1997; Bei and Maas, 1998).
(ii) act as extracellular chemical signals (such as bone morphogenetic proteins 
[BMP’s], fibroblast growth factors [FGF’s] and epidermal growth factors 
[EGF’s] etc.) or their cognate receptors (Neubuser et al., 1997; Kettunen and 
Thesleff, 1998).
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To date, more than 200 genes expressed in developing teeth have been studied 
(http://honeybee.helsinki.fi/toothexp: Nieminen et al., 1998). It is suggested that the spatial 
and temporal expression of these genes determines the position and the state of 
differentiation of individual cells in tooth morphogenesis (Thesleff, 2000).
1.3 Fibroblast growth factors (FGF’s): members of the heparin binding growth 
factor family (HBGF)
Fibroblast growth factors (FGF’s) form one of the larger groups of signaling molecules 
expressed in a variety of tissues and are believed to play a crucial role in successive stages 
of organogenesis. FGF’s were initially isolated as proteins capable of stimulating growth of 
fibroblasts and demonstrated the ability to bind with heparin/heparan sulfate. Originally, 
FGF’s were classified as members of the “heparin-binding growth factor” (HBGF) 
superfamily (Masahiro et al., 2001). The member proteins of this family are structurally 
related, but genetically distinct (Kuzis et al., 1996; Stem et al., 1997).
The polypeptides of this family bind to the sulfated glycosaminoglycan heparin by their 
overlapping mitogenic and neurotropic actions on a variety of mesodermal, ectodermal and 
neuroectodermal cell types (Burgess and Maciag, 1989; Kuzis et al., 1996; Courlier et al, 
1997; Guillonneau et al., 1998). To date, 22 members of this family of mitogens have been 
identified (Omitz and Itoh, 2001; Karabagli et al., 2002) in organisms ranging from 
nematodes to humans. In vertebrates, the 22 members of the FGF family range in molecular 
mass from 16 to 34 KDa. They share 13-71% of the amino acid sequence in a core region 
of 120 amino acids and demonstrate similar activities in many biological assays (Kuzis et 
al., 1996; Courlier et al., 1997; Ford et al., 1997; Stem et al., 1997; Guillonneau et al., 
1998; Ohbayashi et al., 1998; Barasch, 1999; Omitz and Itoh, 2001). Member proteins of
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this family are highly conserved across mammalian species (Omitz and Itoh, 2001). 
Although considerable homology exists in the structure of FGF’s, their functions differ 
significantly.
FGF-1 and FGF-2 were the first two members to be isolated, and are the most studied 
members of this multipotent family of polypeptides (Burgess and Maciag, 1989). FGF-1 
and FGF-2 are monomers of approximately 155 amino acids in chain length, with 
molecular weight of about 18 KDa (Okada-Ban et al., 2000). These two members share 
about 55% amino acid identity as well as both lack the classical peptide signalling sequence 
(Rifkin and Moscatelli, 1989). Although there is almost universal tissue distribution and 
action of FGF-2 and the wide distribution of FGF-1, many other members of this family are 
also expressed during the development of many organs. Some other important members of 
this family are FGF-3 to -9. FGF-3 to -6 were isolated as proto-oncogenes from tumor cells 
(Dickson and Peter, 1987; Miki et al., 1991) and were designated as FGF-3 (int-2), FGF-4 
(Kaposi sarcoma FGF/K-FGF or hst/ a product of hst-1 oncogenes), FGF-5 and FGF-6 
(KGF). FGF-7 also called keratinocyte growth factor (KGF) was identified based on its 
selective mitogenicity for epithelial cells but not for fibroblasts (Finch et al., 1989). FGF-8 
(androgen-induced growth factor/AIGF) was isolated from a murine androgen-dependent 
carcinoma (Tanaka et al., 1992). FGF-9 initially described as glial- activating factor (GAF), 
was isolated from a human glioma cell line (Miyamoto et al., 1993). In addition, a group of 
four fibroblast homologous growth factors (FHF’s) have been identified and which play an 
important role in nervous system development. They are designated as FGF-11 to -14 
(Smallwood et al., 1996). The discovery of new members of this family has been frequent 
and in future, more functions related to this group of polypeptides may be defined.
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1.4 Historical perspective of fibroblast growth factor-2 (FGF-2)
FGF’s in general were first isolated in the 1970’s from bovine brain based on their 
mitogenic and angiogenic activities (Armelin, 1973). In 1975, Gospodarowicz specifically 
identified FGF-2 from bovine pituitary gland extracts based on its mitogenic activity in the 
Balb/c3T3 cell line. This growth factor was characterized as a single peptide of the 
molecular weight of 18 KDa. FGF-2 is produced as a 155 amino acid precursor out of 
which the mature 146 amino acid residue recombinant form has been synthesized (Moy et 
al., 1996; Okada-Ban et al., 2000). Its structure has been determined using nuclear 
magnetic resonance [NMR] (Moy et al., 1996). This growth factor is also called basic 
fibroblast growth factor (b-FGF) because of its basic isoelectric point pl= 9.6 (Okada-Ban 
et al., 2000). The primary structure of FGF-2 is highly conserved among the mammals 
including humans, bovines and rats (Rifkin and Moscatelli, 1989).
1.5 FGF-2: a pluripotent growth factor
FGF-2 is a pluripotent growth factor. Several biochemical and immunocytochemical 
studies have demonstrated the presence of this mitogen in a variety of rat, human and 
mouse tissues. These include brain (Bean et al., 1991; Kuhn et al., 1997), heart (Pasumarthi 
et al., 1996), pituitary and adrenal glands (Grothe and Unsicker, 1990), thyroid gland 
(Grothe and Unsicker, 1990), embryonic tissues (Karabagli et al., 2002), in the developing 
retina of different species (Me Farlane et al., 1998; Patel and McFarlane, 2000), in ovine 
skin during follicle morphogenesis (Du-cros et al., 1993) and in blood vessels (Poole et al., 
2001). In addition, this growth factor has also been immunolocalized in structures such as 
the adult rat submandibular salivary gland (Amano et al., 1993) and human and rat (adult
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and embryonic) kidney (Cancilla et al., 1999; Floege et al., 1999) which undergo branching 
morphogenesis.
This multifunctional growth factor demonstrates a broad spectrum of biological activities 
and mediates its effects through both paracrine and autocrine mechanisms (Sato and Rifkin, 
1988; Bashkin et al., 1989; Jackson et al., 1992). These include cell proliferation (Rifkin 
and Moscatelli, 1989), differentiation and cell migration (Cauchi et al., 1996; Mansukhani 
et al., 2000) and skeletogenesis (Mansukhani et al., 2000). FGF-2 is also believed to be a 
mitogen for the process of angiogenesis of endothelial and smooth muscle cells (Reiland 
and Repraeger, 1993; Floege et al., 1999; Kan et al., 1999). In Xenopus levis, amphibians 
and mammals, FGF-2 induces induction of embryonic mesoderm (Kimelman et al., 1988) 
and pattern formation (Amaya et al., 1993; Labonne and Whiteman, 1994) as well as 
control, expression and deposition of the extracellular matrix components (Aktas and 
Kayton, 2000). This cytokine has also been implicated in the early morphogenesis in 
mammals (Feldman et al., 1995). In addition, FGF-2 plays a critical role in bone growth 
and development and participates in the process of chondrogenesis and osteogenesis (Cohn 
et al., 1995; Sutherland et al., 1996; Mansukhani et al., 2000).
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1.6 Mechanism of action of FGF-2
FGF-2, as a member of the FGF family of ligands exerts it biological effects through a dual 
receptor system (Cancilla et al., 1999). These receptors are believed to participate in 
epithelio-mesenchymal interactions and thus act as the main vehicles of organogenesis 
(Omitz et al., 1996). The first component of this system consists of specific transmembrane 
tyrosine kinase receptors that are similar in structure to other transmembrane protein kinase 
receptors (Lee et al., 1989; Stem et al., 1997; Cancilla et al., 1999). To date, four 
membrane bound FGF-receptors (FGFR-1 to FGFR-4) have been identified (Reiland and 
Repraeger, 1993; Kan et al, 1999) and their existence is documented in all contemporary 
vertebrates (Courlier et al., 1997). They bind to FGF’s with high affinity (Basilico and 
Moscatelli, 1992). These receptors are monomeric in their native state and dimerize after 
binding with an FGF ligand. This dimerization activates tyrosine kinase and thus induces 
the effect of this growth factor through multiple signaling pathways.
The second component of the dual receptor system is the polysaccharide component 
(heparin like molecules) of the heparan sulfate proteoglycans (HSPG’s) present on the cell 
surfaces and in the extracellular matrix (ECM) [Ruoslahti and Yamaguci, 1991; Wiedlocha 
et al., 1994]. They bind FGF’s with low affinity and do not participate in the signalling 
cascade. However, HSPG’s provide an extracellular storage compartment and thus protect 
FGF’s from degradation. In addition, in response to the internal or external stimuli, e.g. 
proteolytic processing of the extracellular matrix or phophorylation, these thermostable 
“FGF-heparin like polysaccharide” complexes regulate the bioavaibality of FGF’s by 
increasing the affinity of FGF’s for FGFR’s (Yayon et al., 1991; Givol and Yoyon, 1993; 
Aviezer et al., 1994; Roghani et al., 1994 ; Fannon and Nugent, 1996; Repraeger, 2000).
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1.7 FGF’s and tooth development
Recent work has shown that a variety of fibroblast growth factors play a critical role in 
tooth morphogenesis. For example, FGF-3 (int-2), FGF-4 (hst, kFGF), FGF-7 (KGF), and 
FGF-8 (AIGF) mRNAs have been detected in the developing tooth (Wilkinson et al„ 1989; 
Niswander and Martin, 1992; Finch et al., 1995; Neubiiser et al., 1997). Most of these 
studies, however, primarily focused on the expression of mRNA transcripts of FGF’s 
during the early stages of tooth development. In addition, Cam et ah (1992) and Russo et 
ah (1997) have reported the immunolocalization of FGF-1 and FGF-2 in early stages of 
tooth development. All these studies however, did not extend their work to unfold the role 
of FGF-2 in the development of the root of the tooth. Root morphogenesis, which follows 
the formation of the crown of the tooth, also exhibits a classical example of epithelio- 
mesenchymal interaction. The root of the tooth consists of dentin and cementum (Ten Cate, 
1998). The process of root development begins with the proliferation of epithelial cells of 
the external and internal dental epithelium from the cervical loop of the dental organ to 
form a double layer of cells known as Hertwig’s epithelial root sheath (epithelial 
derivative). Hertwig’s epithelial root sheath grows around the dental papilla between the 
papilla and the dental follicle (oral ectomesenchymal derivatives) and encloses the dental 
papilla completely, except for the apical portion of the papilla. The rim of this root sheath 
(the epithelial diaphragm) encloses the primary apical foramen. The inner epithelial cells of 
the root sheath progressively enclose the gradually expanding dental papilla, and initiate the 
differentiation of odontoblasts from the cells at the periphery of the dental papilla 
(ectomesenchymal derivative). These cells eventually form the dentin of the root (Ten 
Cate, 1998). The stretching of the epithelial root sheath of Hertwig eventually results in its 
fragmentation. This is followed by the migration of the innermost cells of the dental follicle
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(ectomesenchymal derivative) towards the root dentin surface where they, in turn, 
differentiate into cementoblasts. The cementoblasts secrete cementoid, which later on in 
development will mineralize to form cementum and form part of the root (Avery, 2001). 
The outermost cells of the dental follicle differentiate into osteoblasts and form the alveolar 
bone. The more centrally located cells of the dental follicle differentiate into fibroblasts, 
which take over the role of collagen fibre production. These collagen fibres become 
embedded in both cementum and bone as Sharpey’s fibres (Avery, 2001).
Previous studies by Cam et al. (1992) and Russo et al. (1997) elucidated the expression of 
FGF-2 in the cells differentiating from the dental papilla and dental follicle in the region of 
the crown during early tooth development. These investigators suggested that FGF-2 
expression is specific in the developing crown with progression in time. It is likely that 
later events associated with root development such as root dentin formation, alveolar bone 
formation, cementogenesis and the development of the periodontal ligament may be 
regulated by the expression of fibroblast growth factor-2. Thus, using immunocytochemical 
techniques, the aim of this study is to examine the pattern of localization of FGF-2 in 
various cell types and tissues during the development of the root of maxillary and
mandibular molars and incisors.
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CHAPTER TWO
2.0 MATERIALS AND METHODS
2.1 Ethical Clearance
Ethical clearance for this study was obtained from the Animal Ethics Screening 
Committee o f the University o f the Witwatersrand (AESC NO: 2001/ 012/ A).
2.2 Tissues
Animals were obtained from the Central Animal Unit o f the University of the 
Witwatersrand. Thirty-six (36) mouse pups (strain MF-1) o f different stages were used 
for this project. Tissue from six age groups o f post-natal mice was studied (i.e. post­
natal days 9, 10, 12, 16, 20 and 24). Six mice from each o f the age groups were studied. 
The chronological ages o f the mice for each stage o f the project were based on mouse 
molar tooth development as described by Cohn (1956). The submandibular gland of 
10-week old rat (strain Sprague-Dawley) was used as a positive control for 
immunocytochemistry (Amano et al., 1993).
2.3 Animal sacrifice
The mouse pups were killed with an overdose (150mg/ kg body weight) of sodium 
pentobarbitone (Eutha-naze, Centaur labs), administered intraperitoneally. The animals 
were decapitated and the region o f the face anterior to the external acoustic meatus was 
isolated. The calotte and brain tissue o f each specimen was then also removed. The 
tissue was further bisected in the mid-sagittal plane to divide the maxilla and mandible 
into two symmetrical halves.
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2.4 Tissue fixation
The tissues were fixed by immersion in a 3.7% formaldehyde/ zinc fixative [also called 
zinc formalin] (Electron Microscopy Sciences, Cat #15675-01), for 36 hours. The 
rationale for using zinc in 3.7% formaldehyde as a fixative is that, it prevents or at least 
inhibits cross linking by formaldehyde; it holds macromolecules in their native 3- 
dimensional confirmation and it creates superior morphological details at the level of 
the light microscope (Dapson, 1993).
2.5 Tissue decalcification
Zinc formalin fixed tissues were decalcified using 5% formic acid as an acid- 
decalcifying agent (Stevens et al., 1996). Tissues were immersed in 5% formic acid 
(from 72 to 120 hrs) at room temperature depending on the stage o f development of the 
mice. A chemical test called the “Calcium oxalate test” adapted from Amim (1935) and 
Clayden (1952) and as described by Stevens et al. (1996) was performed to test for the 
completion o f decalcification [Appendix I].
2.6 Tissue processing and sectioning
Following decalcification, the tissues were routinely processed in an enclosed 
automated tissue processor (SHANDON, citadel 1000) through a graded series of 
alcohols followed by two changes of chloroform and cleared in xylene. Processed mice 
and rat tissues were embedded in paraffin wax. Sagittal sections (5 pm thick) from each 
mouse and rat tissue were cut on a sledge microtome (Leica 1400, Leica Instruments 
GmbH, Germany). The sections were mounted on aminoalkylsilane-treated slides 
[Appendix II] for immunocytochemistry (Rentrop et al., 1986). Every tenth section was
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stained with haematoxylin and eosin [Appendix III] for routine histological examination 
of both the mandibular and maxillary molars and their supporting structures (Steven and 
Wilson; 1996).
2.7 Primary Antibody
Polyclonal rabbit anti-FGF-2 antibody [FGF-2 (147) K, Cat # sc-79K, Lot #F020] was 
used (Santa Cruz Biotechnology, Inc. USA). This affinity purified, polyclonal rabbit 
anti-FGF-2 antibody is raised against a peptide mapping within the amino terminal 
domain o f FGF-2 o f human origin. It differs from corresponding mouse and chicken 
sequences by a single amino acid (Dionne et al., 1990). As specified by the 
manufacturer, this polyclonal antibody is mouse, rat and human reactive. Concentration 
runs were performed at 1:200, 1:100 and 1:80 to determine the optimal concentration of 
the primary antibody required with the least amount o f background staining. The 
dilution was performed with 10 mM phosphate buffered saline (PBS), pH 7.4 and 0.1% 
Tween-20 [Appendix IV] as per manufacturer’s instructions and finally the primary 
antibody was used at a concentration o f 1:80.
2.8 Secondary Antibody
Biotinylated goat anti-rabbit pre-diluted secondary antibody (Santa Cruz Biotechnology, 
Inc. USA) was used. The secondary antibody was supplied with the ImmunoCruz™ 
staining system, which was used as a detection system.
Chapter two- Materials and Methods 14
2.9 Blocking Antigen (Peptide)
Blocking antigen (Peptide) (FGF-2 [147] P, Cat # sc-79 P, Lot # J021) was used for 
absorption control (Santa Cruz Biotechnology, Inc. USA). This consisted of 100 pg 
peptide in 0.5 ml phosphate buffered saline (PBS) with 0.1% sodium azide and 100 pg 
bovine serum albumin (BSA).
2.10 Immunohistochemical staining system
Rabbit ImmunoCruz™ staining system (Cat #sc-2051, Santa Cruz Biotechnology, Inc. 
USA) [Appendix V] was used as the immunohistochemical staining system. This 
staining system differs from other ABC systems in that it utilizes an HRP-Strept-avidin 
complex rather than the avidin/biotynalated HRP complex. The advantage of this 
staining system is that all the reagents are supplied in pre-diluted form to the optimal 
concentrations, needed for tissue staining.
2.11 Chromogen
The chromogen used was 3,3' diaminobenzidine tetrahydrochloride (DAB). It produces 
a gold-brown stain and was supplied as part o f the Rabbit ImmunoCruz™ staining 
system (Cat #sc-2051, Santa Cruz Biotechnology, Inc. USA)
2.12 Immunocytochemistry
Fibroblast growth factor-2 (FGF-2) localization on the tissue sections was performed 
using the avidin-biotin immunoperoxidase technique adapted from Hsu et al. (1981) and 
Bratthauer (1994). All steps were performed according to the research applications
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procedure supplied by Santa Cruz Biotechnology, Inc. USA, the manufacturer of the 
primary antibody, secondary antibody and detection system.
All incubations were performed at room temperature in a humidified chamber unless 
otherwise stated. Briefly the sections were deparaffinized in three changes of xylene and 
rehydrated through a graded series o f alcohols. The sections were then washed in de­
ionized water for 5 minutes in the presence of a magnetic stirrer. Excess liquid from the 
slides was aspirated.
Antigen unmasking was performed at this stage by microwave heat treatment. For this 
technique, slides mounted with sections were placed in a coplin jar filled with 10 mM 
sodium citrate buffer, pH 6.0 [Appendix VI]. The sections were heated at 95° C for 5 
minutes in a standard microwave oven. The coplin jar was then topped up with fresh 
citrate buffer and sections were again heated at 95° C for a further 5 minutes. The slides 
were allowed to cool in the buffer for approximately 20 minutes. The sections were then 
rinsed and washed twice in de-ionized water. Excess liquid from the sections was 
drained. Appropriate care was taken to keep the sections wet and moist. The sections 
were incubated with 1% hydrogen peroxide in de-ionized water for 10 minutes to 
quench intrinsic endogenous peroxidase activity, followed by two 5-minutes washes in 
10 mM phosphate buffered saline (PBS), pH 7.4 and 0.1% Tween-20. The sections were 
then incubated for 20 minutes in 1-3 drops o f 5% normal goat serum. The sections were 
drained and wiped carefully around the tissue to remove excess fluid and were 
immediately incubated for two hours at room temperature, in a moist chamber with 
polyclonal rabbit anti-FGF-2 antibody (1:80 diluted with PBS). The sections were then 
rinsed and washed twice with PBS and 0.1% Tween-20 in the presence of a magnetic 
stirrer. The sections were incubated with 1-3 drops o f biotinylated goat anti-rabbit 
secondary antibody (pre-diluted) for 30 minutes, followed by two brief washes in PBS
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and 0.1% Tween-20. Excess liquid was drained from the sections. The site of the 
immunoreaction was made visible by incubating the sections with 1-3 drops of HRP- 
Streptavidin complex for 30 minutes, followed by a brief wash with PBS and 0.1% 
Tween-20. The sections were once again wiped around the tissue to remove excess 
fluid, followed by incubation with 1-3 drops 3', 3'-diaminobenzidine tetrahydrochloride 
(DAB). This reagent was supplied as an HRP substrate mixture [Appendix VII] with the 
Immuno-cruz staining system.
The sections were developed for 20 minutes until the desired stain intensity developed. 
The sections were then washed twice for 5-minutes each in de-ionized water in the 
presence o f a magnetic stirrer, dehydrated through ascending grades of alcohol and 
cleared in two changes o f xylene. Finally, the sections were mounted in a permanent 
mounting medium, Entellan (Merck, Germany).
2.13 Negative Controls
Negative controls for immunocytochemistry were performed. The rationale for the use 
o f the negative controls was to ensure that immunolocalization in the test sections was 
not due to binding o f either the primary antibody or the secondary antibody alone and/or 
o f a non-specific immunoglobulin. This confirms that the primary antibody is indeed the 
critical link for any “staining” to occur. Negative controls were carried out on a section 
adjacent to the section on which reaction had been localized.
The following negative controls were performed:
(a) Exclusion of the primary antibody and replacement with normal rabbit 
serum (supplied with ImmunoCruz™ staining system)
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(b) Exclusion o f the primary antibody and replacement with phosphate buffered 
saline (PBS)
(c) Exclusion of the secondary antibody and replacement with normal rabbit 
serum (supplied with ImmunoCruz™ staining system)
(d) Exclusion o f the secondary antibody and replacement with phosphate 
buffered saline (PBS)
2.14 Positive Controls
A positive control section was used with every immunocytochemical run. For this 
purpose, tissues in which FGF-2 had previously been localized such as the 
submandibular gland of an adult rat were used as a positive control. Epithelial cells 
lining the striated and excretory ducts and the granular convoluted tubules o f the 
submandibular gland o f a 10-week old adult rat were used (Amano et al., 1993).
2.15 Absorption (Peptide neutralization) Control
An absorption (peptide neutralization) control was performed to determine the 
specificity o f the primary antibody. Polyclonal rabbit anti-FGF2 antibody (FGF-2 [147] 
K, at a concentration o f 1:80) was combined with a five-fold excess of blocking antigen 
peptide (FGF-2 [147] P) in 500 pi o f PBS and incubated overnight at 4°C. Sections of 
the tooth adjacent to a section depicting the localization o f the antibody were incubated 
with preabsorbed antibody, substituted for the primary antibody.
2.16 Counterstaining
All the sections were counterstained briefly for 10 seconds with haematoxylin.
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CHAPTER THREE
3.0 RESULTS
In the present study, the pattern o f expression of fibroblast growth factor-2 in the 
developing root of teeth was examined. Six stages o f the developing roots of teeth from 
mice were selected (post-natal days 9,10,12,16, 20 and 24).
This study did not attempt to quantify the expression of FGF-2, but rather, the 
immunocytochemical localization of FGF-2 was observed both spatially and 
temporally.
Photographic representations o f teeth are oriented according to the position o f the tooth 
either in the developing maxillary or mandibular arch. Different developing cell types at 
various stages o f development from undifferentiated mesenchymal cells o f the dental 
papilla were identified by their position e.g. odontoblasts in relation to the pulp cavity. 
Similarly, the differentiating ectomesenchymal cells in the central part of the developing 
periodontal ligament were identified as probably being the presumptive fibroblasts of 
the periodontal ligament.
For antigen retrieval, sections were boiled in 10 mM citric acid buffer twice for five 
minutes in a microwave oven. This technique was adopted as per manufacturer’s 
recommendation, to be used with the specified polyclonal antibody. This technique 
allows for the unmasking of further/additional antigen sites over the entire section.
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Although the microwave technique proved useful in unmasking antigen sites, the 
sections tended to lift with some loss of morphological details. This may be due to the 
fact that the thickness o f the sections on the slide varied between areas o f soft tissues to 
some “harder” tissue e.g. minor areas o f calcification still present in the teeth.
Variation in localization of FGF-2 with respect to specific cellular regions occurred i.e. 
localization was most frequently found in the cytoplasm and the extracellular matrix and 
occasionally in the nuclei at different stages of morphogenesis and differentiation.
3.0.1 Positive and Negative Controls for Immunocytochemistry
For the positive control, sections o f the submandibular gland of a male adult rat were 
used. Intense FGF-2 immunoreactivity was observed in the granular convoluted tubules, 
predominantly in the agranular pillar cells o f the submandibular gland (Fig. 1) as 
described by Amano et al. (1993).
For the negative control, sections o f tooth, adjacent to a section showing 
immunolocalization o f FGF-2, from all the animals at each stage examined, were 
incubated with phosphate buffered saline (PBS) or normal rabbit serum (NRS) in place 
o f either the primary or the secondary antibodies respectively. In these sections, no 
evidence o f FGF-2 protein expression was detected (see e.g. Fig. 2a) compared to the 
adjacent FGF-2 labeled section (Fig. 2b). This confirmed that the primary antibody 
indeed was responsible for the immunolocalization o f FGF-2 in the sections.
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3.0.2 Absorption (Peptide neutralization) control
For the absorption control, sections o f the tooth, adjacent to a section depicting the 
localization o f the antibody were used. These sections were incubated with pre-absorbed 
antibody (antigen-antibody incubated overnight at 4°C) substituted for the primary 
antibody. In these sections, no evidence o f irnmunoreactivity o f FGF-2, with minimal 
background was observed (Fig. 3) compared to the adjacent section in which the FGF-2 
antibody had been applied and in which localization was evident (Fig. 2b). This proved 
that the staining was not due to a non-specific immunoglobulin and/or secondary 
antibody binding to the sections, but due to the primary antibody itself.
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Figure 1 Positive control. Representative section o f the submandibular gland of 
an adult male rat. Immunolocalization o f FGF-2 occurs in the granular 
convoluted ducts and predominantly in the agranular pillar cells ( > ). 
Counterstained with Meyer’s haematoxylin. Bar: 20 pm.
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Figure 2(a) Negative control. Representative section o f the developing root of a 
maxillary first molar of a 10-day post-natal mouse pup. Substitution of 
the primary antibody with normal rabbit serum (NRS). Note that no 
immunolocalization ( ) is observed in the odontoblasts (od),
ameloblasts (am), presumptive odontoblasts (dmc) and in presumptive 
osteoblasts (dob). Counterstained with Meyer’s haematoxylin. Bar: 20 
pm.
Figure 2 (b) Representative section, adjacent to that in figure 2(a).
Immunolocalization of FGF-2 occurred in the odontoblasts (od) lining 
the pulp chamber and the pulp canal, in ameloblasts (am), in individual 
differentiating ectomesenchymal cells (dmc) [presumptive odontoblasts] 
and in a few differentiating ectomesenchymal cells (dob) [presumptive 
osteoblasts] lining the developing alveolar bone (avb). Counterstained 
with Meyer’s haematoxylin. Bar: 20 pm.
Figure 3 Absorption control. Representative section, adjacent to that in figure 2 
(b). Substitution o f the primary antibody with preabsorbed antibody. 
Note no immunoreactivity, with minimal background is observed in the 
cells, namely odontoblasts (od), ameloblasts (am), presumptive 
odontoblasts (dmc) and osteoblasts (dob), as compared to the tissue 
section in figure 2 (b). Counterstained with Meyer’s haematoxylin. Bar: 
20 pm.
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3.1 Immunolocalization of FGF-2 in the root of the murine tooth on post-natal 
day 9
The teeth o f post-natal day 9 mice pups were the earliest stage examined for the 
expression o f FGF-2 (Fig. 4). Every tenth (10th) section from each animal was stained 
routinely with haematoxylin and eosin stain to examine the tooth morphology and the 
development. In the developing maxillary and mandibular arches, all three molar teeth 
(i.e. first, second and third), as well as the central incisors were present.
The development o f the maxillary molars lagged slightly behind that of the mandibular 
molars. However, by post-natal day 9, the shape o f the future crown of the first and 
second molars in the maxillary and mandibular arches had been established. In both 
arches, the first and second molars were in the late bell stage, while the third molar was 
still in the cap stage.
In both sets o f teeth, differentiating ectomesenchymal cells were present in the pulp 
chamber, in the developing periodontal ligament and around the developing spicules of 
the alveolar bone. By this stage, cells of the inner dental epithelium had differentiated 
into ameloblasts and the process o f amelogenesis was in progress (Fig. 4). The presence 
o f enamel was noted in the sections (Fig. 4). The cells o f the outer dental epithelium and 
stellate reticulum had lost their individual identity. The stratum intermedium was 
observed as a stratified layer of epithelial cells adjacent to the ameloblast layer (Fig. 4). 
The formation o f the diaphragm of the epithelial root sheath had begun (Fig. 4).
In the maxillary first molar, root development had just started (Fig. 4), while in the 
second and third molar, the diaphragm of the epithelial root sheath was still in the initial
stage o f formation.
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In the mandibular first molar, evidence o f formation of the diaphragm of the epithelial 
root sheath was observed and a condensation of the differentiating ectomesenchymal 
cells was noted in the apical part o f the teeth. The second mandibular molar did not 
show the formation o f a diaphragm of the epithelial root sheath at this stage. The dental 
follicle was evident.
In both the maxillary and mandibular central incisors, differentiating odontoblasts and 
ameloblasts were seen (Figs. 5 and 6). The periodontal ligament was still 
undifferentiated (Figs. 5 and 6). Bony spicules forming the developing alveolar bone 
were observed (Figs. 5 and 6). The formation o f the diaphragm of the epithelial root 
sheath was complete and had progressed along the apical axis o f the root formation.
Thus, on post-natal day 9, as seen in Fig. 4, the presence o f ameloblasts, odontoblasts, 
enamel, dentin, differentiating ectomesenchymal cells (presumptive fibroblasts) in the 
pulp chamber, region of the developing root (presumptive odontoblasts) and lining the 
developing alveolar bone (presumptive osteoblasts) was noted both in mandibular and 
maxillary teeth. Cementum and cementoblasts were absent at this stage.
In general, immunolocalization of FGF-2 both in the maxillary and mandibular molars 
and incisors was evident (Refer to Table 3.1). In the ameloblasts, FGF-2 distribution 
was primarily in the cytoplasm (Figs. 6 and 7). In the differentiated odontoblasts, 
distribution o f FGF-2 was homogeneous in the cytoplasm (Figs. 5, 6 and 7). However, 
in a few differentiating ectomesenchymal cells o f the pulp chamber and in individual 
cells o f the developing periodontal ligament (presumptive fibroblasts), localization of
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FGF-2 was noted in the nuclei and extracellular matrix (Figs. 5 and 6). FGF-2 was also 
localized to the nuclei and the extracellular matrix of the differentiating 
ectomesenchymal cells lining the developing alveolar bone (presumptive osteoblasts) 
and in the presumptive odontoblasts in the region o f root development (Figs. 5 and 6). 
The stratum intermedium did not show immunolocalization o f the antibody (Fig. 7). In 
the ameloblast cell layer, most of the cells were immunoreactive to the FGF-2 antibody 
and a uniform pattern o f immunolocalization was observed (Figs. 6 and 7).
The odontoblasts located more coronally in the developing root exhibited more intense 
localization o f FGF-2 as compared to those located apically, although this was not 
quantifiable (Figs. 5, 6 and 7). A few of the presumptive odontoblasts in the region of 
the root demonstrated intense localization of FGF-2, primarily in the nucleus (Fig. 5).
A few presumptive fibroblasts in the pulp chamber and in the developing periodontal 
ligament as well as a few presumptive osteoblasts in the region of developing alveolar 
bone also exhibited evidence for immunoreactivity for FGF-2 in the nuclei (Figs. 5 and 
6).
As referred in Table 3.1, although faint “localization” o f FGF-2 was also observed in 
the dentin (Figs. 6 and 7), it was not as definitive as when localized in specific cells.
The stratum intermedium and the predentin exhibited no evidence of 
immunolocalization of FGF-2 (Refer to Table 3.1 and Fig. 7).
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Table 3.1 Immunolocalization of FGF-2 in the root of the murine tooth on 
post-natal dav 9
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(+): Positive for immunoreactivity for FGF-2
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Figure 4 Representative section o f a maxillary first molar of a 9-day post-natal 
mouse pup. Note the presence o f the ameloblasts (am), enamel (e), dentin 
(d), predentin (pd), odontoblasts (od), stratum intermedium (si), 
diaphragm of the epithelial root sheath (erd) and differentiating 
ectomesenchymal cells (dmc) in the pulp chamber and in the region of 
the future root development. Haematoxylin and eosin stain. Bar: 50 pm
Figure 5 Representative section of the developing root of a maxillary central 
incisor of a 9-day post-natal mouse pup. Immunolocalization o f FGF-2 in 
the cytoplasm of the odontoblasts (od), in a few differentiating 
ectomesenchymal cells (dfb) o f the pulp chamber [presumptive 
fibroblasts], in individual differentiating ectomesenchymal cells (pdlfb) 
o f the periodontal ligament [presumptive fibroblasts] and in the 
differentiating ectomesenchymal cells (dob) [presumptive osteoblasts] 
lining the developing alveolar bone (avb). Note intense localization of 
FGF-2 antibody in the nuclei o f differentiating ectomesenchymal cells 
(dmc) [presumptive odontoblasts] at the apical end o f the root region. 
Counterstained with Meyer’s haematoxylin. Bar: 10 pm.
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Figure 6 Representative section o f the developing root o f a maxillary central 
incisor of a 9-day post-natal mouse pup. Note FGF-2 immunoreactivity 
in a few differentiating ectomesenchymal cells (dob) [presumptive 
osteoblasts] lining the developing alveolar bone (avb), in the ameloblasts 
(am), the odontoblasts (od) and in a few individual differentiating 
ectomesenchymal cells (dfb) o f the pulp chamber [presumptive 
fibroblasts]. Also note a very faint signal in the early deposition of dentin 
(d). Counterstained with Meyer’s haematoxylin. Bar: 10 pm.
Figure 7 Representative section of a maxillary first molar o f a 9-day post-natal 
mouse pup. Note FGF-2 immunolocalization in the cytoplasm of the 
odontoblasts (od) and ameloblasts (am). Also note a very faint signal in 
the early deposition o f dentin (d). No immunolocalization o f FGF-2 
occurred in the stratum intermedium (si) and predentin (pd). 
Counterstained with Meyer’s haematoxylin. Bar: 10 pm.
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3.2 Immunolocalization of FGF-2 in the root of the murine tooth on postnatal 
day 10
On post-natal day 10, sections stained with haematoxylin and eosin showed the 
presence o f all three developing molars and the central incisors as in the previous stage 
i.e. 9-days postnatal. The first and second molars were in the late bell stage while the 
third molars were now in the early bell stage of tooth development (Fig. 8). In the first 
molar, maturation o f enamel at the tips of the cusp and the beginning o f root formation 
was observed. In the second molar, dentin and enamel were observed but root formation 
had not yet begun. The presumptive furcation zone o f the first and second molars was 
noted and a condensation o f the differentiating ectomesenchymal cells (presumptive 
odontoblasts) was observed. Formation of the diaphragm of the epithelial root sheath 
was evident in the third molars as well as the presence o f the stratum intermedium (Fig. 
8).
Once again, as seen in the Fig. 8, the presence of various structures and cells types 
namely the ameloblasts, odontoblasts, enamel, dentin, predentin, presumptive 
odontoblasts in the region o f the developing root, presumptive fibroblasts of the pulp 
chamber, developing periodontal ligament and the developing alveolar bone was noted 
at this stage. Cementoblasts and cementum were absent.
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As seen in Table 3.2 and Figs. 9, 10 and 11, cytoplasmic as well as nuclear localization 
of FGF-2 was present both in the maxillary and the mandibular molars and incisors of 
10-day postnatal mice pups. Ameloblasts and odontoblasts exhibited evidence of 
cytoplasmic immunoreactivity with a few cells having nuclear reactivity (Figs. 9 and 
10). Presumptive fibroblasts, in the pulp chamber and in the developing periodontal 
ligament, and presumptive osteoblasts lining the developing alveolar bone exhibited 
nuclear immunoreactivity. There was also some localization for FGF-2 in the 
extracellular matrix (Figs. 9, 10 and 11). The stratum intermedium, however, did not 
show immunoreactivity (Table 3.2 and Figs. 9 and 10).
In the ameloblast layer, a homogeneous distribution o f FGF-2 was noted in the 
cytoplasm o f most o f the cells (Figs. 9 and 10). A uniform cytoplasmic and nuclear 
localization o f FGF-2 in the odontoblasts was present apically, as root formation 
extended (Fig. 10). Once again, a few presumptive odontoblasts in the region of root 
development showed specific nuclear immunoreactivity for FGF-2 (Table 3.2 and Fig. 
10).
Nuclear and extracellular matrix localization o f the antibody was also observed in 
presumptive fibroblasts of the pulp chamber (Fig. 11). Expression appeared to be 
evident in more cells as compared to the previous stage i.e. post-natal day 9. 
Ectomesenchymal cells o f the dental follicle and cells lining the developing alveolar 
bone were also immunoreactive for FGF-2 (Table 3.2 and Fig. 9). At this stage many 
cells in the dental follicle expressed FGF-2. The dentin, once again showed faint 
immunolocalization, which may or may not be true immunoreactivity (Table 3.2 and 
Fig. 10). Once again, as seen in Table 3.2, the predentin (Fig. 10) and the stratum 
intermedium (Figs. 9 and 10) did not exhibit any evidence o f immunolocalization.
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Table 3.2 Immunolocalization of FGF-2 in the root of the murine tooth 
on post-natal day 10
■*4i'
c'- ;  - h  -  A m -4 4 .-
„
Central F irst Second Third  F irst Second Third
_Incisor M olar M olar M olar M olar M olar M olar
Stratum  interm edium  (si) - - - - - ■ A 3 . . -
Ameloblasts (am) + + + + + + +
Odontoblasts (od) + + + + + + +
Differentiating 
ectomesenchymal cells 
(dmc)
+ + + + + + +
Predentin (pd) - - - - - - -
Dentin (d) + + + + + + +
Zone of Cem entum (c) A A A A A A A
Differentiating 
ectomesenchymal cells in 
the cementum zone (cb)
A A A A A A A
Differentiating + + + + + f: ■ xv ? f ' ' a +
ectomesenchymal cells A »” " V ■ ' .A .. • : ■ y^v-'
lining the developing 
alveolar bone (dob)
V ; v''.'A " A A -
Differentiating 
ectomesenchymal cells in 
the pulp cham ber (dfb)
+ + + + + + +
Differentiating + + + + + + +
ectomesenchymal cells of y_.*! ■ "**
the periodontal ligament 
(pdlfb)
■ -
Legends:
(+): Positive for immunoreactivity for FGF-2
(-): Negative for immunoreactivity for FGF-2
(A): Absent at this stage
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Figure 8 Representative section o f the developing mandibular third molar tooth of 
a 10-day post-natal mouse pup. Note the presence o f ameloblasts (am), 
enamel (e), dentin (d), predentin (pd), odontoblasts (od), stratum 
intermedium (si), epithelial root diaphragm (erd), differentiating 
ectomesenchymal cells (dmc) [presumptive odontoblasts] in the root 
area, developing periodontal ligament (pdl), developing alveolar bone 
(avb) and the differentiating ectomesenchymal cells (dfb) [presumptive 
fibroblasts] in the pulp chamber. Haematoxylin and eosin stain. Bar: 50 
pm.
Figure 9 Representative section o f the developing crown and early root formation 
of a maxillary first molar o f a 10-day post-natal mouse pup. 
Immunolocalization o f FGF-2 in the ameloblasts (am), in the 
odontoblasts (od) and in the differentiating ectomesenchymal cells (dob) 
[presumptive osteoblasts] (ob) lining the developing alveolar bone (avb). 
No localization o f the antibody is observed in the stratum intermedium 
(si). Counterstained with Meyer’s haematoxylin. Bar: 10 pm.
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Figure 10
Figure 11
Representative section o f the developing root of a mandibular third molar 
of a 10-day post-natal mouse pup. Note immunolocalization of FGF-2 in 
the ameloblasts (am), odontoblasts (od) and in individual differentiating 
ectomesenchymal cells (dfb) [presumptive fibroblasts] of the pulp 
chamber. Also note the presence o f dentin (d). The stratum intermedium 
(si) and predentin (pd) are negative for FGF-2. Counterstained with 
Meyer’s haematoxylin. Bar: 10 pm.
Representative section of the pulp chamber o f a maxillary first molar o f a 
10-day post-natal mouse pup. Note localization o f FGF-2 in the nuclei of 
individual differentiating ectomesenchymal cells (dfb) [presumptive 
fibroblasts]. Counterstained with M eyer’s haematoxylin. Bar: 20 pm.
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3.3 Immunolocalization of FGF-2 in the root of the murine tooth on post-natal 
day 12
Sections o f the mice jaws stained with haematoxylin and eosin on post-natal day 12 
showed that enamel maturation was almost complete in the first mandibular molar and 
root formation had progressed. Evidence of enamel maturation and the beginning of 
root formation was also noted in the second and third molars (Fig. 12).
Sections from all the molars demonstrated the presence of enamel and the adjacent 
layer o f ameloblasts, the predentin, dentin and the odontoblasts layer, differentiating 
ectomesenchymal cells (presumptive odontoblasts) in the region of the developing root 
and in the pulp chamber and the developing periodontal ligament and the developing 
spicules o f the alveolar bone (Fig. 12). Evidence o f formation of connective tissue fibres 
in the dental follicle was also noted. Cementoblasts and cementum, once again were 
absent at this stage (Fig. 12).
Once again as seen in Table 3.3 and Figs. 13, 14 and 15, immunolocalization o f FGF-2 
in the maxillary and mandibular molars and the incisors was evident in a number of 
structures namely, the ameloblasts, odontoblasts and the differentiating
ectomesenchymal cell types in different regions.
In the ameloblasts the signal was decreased and a faint cytoplasmic immunolocalization 
of FGF-2 was located (Fig. 15). In the odontoblast cell layer, homogeneous 
cytoplasmic immunolocalization was observed in almost all the cells. As extension of 
the root occurred, more odontoblasts differentiated apically and exhibited 
immunolocalization of FGF-2 (Fig. 13).
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The differentiating ectomesenchymal cells (presumptive odontoblasts) in the apical 
region o f the root exhibited intense nuclear and cytoplasmic immunolocalization for the 
antibody with some evidence in the extracellular matrix (Figs. 14 and 15). The same cell 
type also demonstrated the evidence o f intense localization o f FGF-2 in the presumptive 
furcation zone o f the developing root o f all molars and the incisors (Fig. 14).
Once again, by comparison o f sections, it appeared that the differentiating 
ectomesenchymal cells (presumptive fibroblasts) o f the pulp chamber and of the 
developing periodontal ligament showed immunolocalization of FGF-2 in more cells as 
compared to the previous two stages (Fig. 14). This however was not quantified.
Once again, no immunolocalization for FGF-2 was demonstrated in the predentin (Fig. 
13) and the stratum intermedium (Fig 15) at this stage.
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Table 3.3 Immunolocalization of FGF-2 in the root of the m urine tooth 
on post-natal dav 12
-■': 4 r  f4 * 0 - :  C - ’ V , ' ■' ■ - ' A ■:
Maxillary Mandibular
■
•
\  ■ ■
■ Hiv' 4 i f ' -
■
Central
J.
Incisor
„ *”
First
Molar
Second
Molar
’ ' *v“ ’ 
- ' t .
Third First Second 
Molar Molar Molar
Third
Molar
Stratum intermedium (si) - - - - - -
Ameloblasts (am) + + + + + + +
Odontoblasts (od) + + + + + + +
Differentiating 
ectomesenchymal cells 
(dmc)
+ + + + + + +
Predentin (pd) - - - - -
Dentin (d) - - - - - -
Zone of Cementum (c) A A A A A A A
Differentiating 
ectomesenchymal cells in 
the cementum zone (cb)
A A A A A A A
Differentiating 
ectomesenchymal cells 
lining the developing 
alveolar bone (dob)
+ + + +  + + +
Differentiating 
ectomesenchymal cells in 
the pulp chamber (dfb)
+ + + + + + +
Differentiating 
ectomesenchymal cells of 
the periodontal ligament 
(pdlfb)
+ + + + + + +
Legends:
(+): Positive for immunoreactivity for FGF-2
(-): Negative for immunoreactivity for FGF-2
(A): Absent at this stage
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Figure 12
Figure 13
Representative section o f the developing mandibular third molar of a 12- 
day post-natal mouse pup. Note the presence o f ameloblasts (am), 
enamel (e), dentin (d), predentin (pd), odontoblasts (od), differentiating 
ectomesenchymal cells (dmc) [presumptive odontoblasts], developing 
periodontal ligament (pdl), developing alveolar bone (avb) and the 
differentiating ectomesenchymal cells (dfb) [presumptive fibroblasts] in 
the pulp chamber. Also note the formation o f the root in the apical area. 
Haematoxylin and eosin stain. Bar: 50 pm.
Representative section o f the pulp chamber o f a mandibular third molar 
o f a 12-day post-natal mouse pup. Note the immunolocalization o f FGF- 
2 in individual differentiating ectomesenchymal cells (dfb) o f the pulp 
chamber [presumptive fibroblasts] and in the odontoblasts (od). Also 
note that dentin (d) and predentin (pd) do not show immunolocalization 
of the antibody. Counterstained with M eyer’s haematoxylin. Bar: 10 pm.
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Figure 14
Figure 15
Representative sagittal section o f the furcation zone of a maxillary 
second molar of a 12-day post-natal mouse pup. Note the intense 
immunolocalization of FGF-2 in the differentiating ectomesenchymal 
cells (dmc) [presumptive odontoblasts] while pre-dentin (pd) shows no 
localization of the antibody. Counterstained with Meyer’s haematoxylin. 
Bar: 10 pm.
Representative section of the pulp chamber o f a mandibular second 
molar o f a 12-day post-natal mouse pup. Note the intense 
immunolocalization o f FGF-2 in the differentiating ectomesenchymal 
cells (dmc) [presumptive odontoblasts] and faint immunoreactivity in the 
ameloblasts (am). Also note that the dentin (d) and stratum intermedium 
(si) do not show immunolocalization o f FGF-2. Counterstained with 
Meyer’s haematoxylin. Bar: 10 pm.
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3.4 Immunolocalization of FGF-2 in the root of the murine tooth on post-natal 
day 16
Progression in the development of all the types o f teeth was evident on post-natal day 
16. As seen in Table 3.4 and Fig. 16, no ameloblasts were present. This may be due to 
the fact that by this stage, the ameloblasts had degenerated and disappeared concurrent 
with the eruption of teeth. Also, no evidence o f a stratum intermedium was found from 
this stage onwards (see Table 3.4 and Fig. 16). Evidence of eruption of the first molar 
was noted in both the arches.
By this stage, the process of cementogenesis had started and the presence of acellular 
cementum adjacent to the dentin layer was noted in the developing root. Differentiating 
ectomesenchymal cells (presumptive cementoblasts) o f the dental follicle were opposed 
to the dentin layer (Fig. 16). Fibres of the developing periodontal ligament and the 
formation of the alveolar bone around the root were also noted.
As seen in Table 3.4 and Fig. 16, various cell types with the exception of ameloblasts 
and the stratum intermedium were present at this stage. FGF-2 was localized both in the 
maxillary and mandibular molars and the incisors. As referred to in Table 3.4 and Figs. 
17 and 18, expression o f this protein was evident in the cytoplasm of the odontoblasts, 
in the nuclei o f the differentiating ectomesenchymal cells (presumptive fibroblasts) of 
the pulp chamber and the pulp canal.
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Specific mention should be made o f the differentiating ectomesenchymal cells 
(presumptive odontoblasts) in the apical part o f developing root, which at this stage 
showed very intense immunolocalization, concentrated both in the cytoplasm and in the 
nucleus with some in the extracellular matrix (Figs. 17 and 18).
Immunolocalization o f FGF-2 was still evident in the ectomesenchymal cells 
(presumptive osteoblasts) lining the developing alveolar bone as seen in the previous 
three stages i.e. post-natal days 9, 10 and 12 (Fig. 18).
Differentiating ectomesenchymal cells (presumptive fibroblasts) of the pulp chamber 
and the developing periodontal ligament also demonstrated immunoreactivity for this 
protein and there was faint localization in the extracellular matrix (Figs. 17 and 18).
Once again, as evident in the previous stages, the dentin, the predentin (Figs. 17 and 18) 
and cementum (Fig. 17) did not show any evidence of immunolocalization of FGF-2, at
all.
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Table 3.4 Immunolocalization of FGF-2 in the root of the murine tooth 
on post-natal day 16
Maxillary
■
. ‘-’i*
•
S li lI S f l•ryAse fJ  •« 4'A/vu;* Mandibularz*>i t - ' f  ,*; ■ v • • 1 '
'- , -4 - . \ ' - 
. ■ . V •: ■ ■
Central
Incisor
First
Molar
■
Second
Molar
Av- ‘AV
Third
Molar
First
Molar
Second
Molar
Third
Molar
Stratum intermedium (si) A A A A A A A
Ameloblasts (am) A A A A A A A
Odontoblasts (od) + + + + + + +
Differentiating + 
ectomesenchymal cells 
(dmc)
+ + + + + +
Predentin (pd) - - - - - -
Dentin (d) - - - - - -
Zone of Cementum (c) - - - - - -
Differentiating + 
ectomesenchymal cells in 
the cementum zone (cb)
+ + + + + +
Differentiating + 
ectomesenchymal cells 
lining the developing 
alveolar bone (dob)
+ + + + + +
Differentiating + 
ectomesenchymal cells in 
the pulp chamber (dfb)
+ + + + 4 - +
Differentiating + 
ectomesenchymal cells of 
the periodontal ligament 
(pdlfb)
+ + + + + +
Legends:
(+): Positive for immunoreactivity for FGF-2
(-): Negative for immunoreactivity for FGF-2
(A): Absent at this stage
Chapter three-Results 50
Figure 16
Figure 17
Figure 18
Representative section o f the developing maxillary second and third 
molar o f a 16-day post-natal mouse pup. Note the presence of dentin (d), 
predentin (pd), odontoblasts (od), developing periodontal ligament (pdl), 
developing alveolar bone (avb), cementoblasts (cb) and the 
differentiating ectomesenchymal cells (dfb) of the pulp chamber 
[presumptive fibroblasts]. Haematoxylin and eosin stain. Bar: 50 pm. 
Representative section of the developing root o f a maxillary third molar 
o f a 16-day post-natal mouse pup. Note immunolocalization o f FGF-2 in 
the odontoblasts (od), in the differentiating ectomesenchymal cells (dmc) 
[presumptive odontoblasts] in the apical zone o f the developing root, in a 
few differentiating ectomesenchymal cells (dfb) of the pulp chamber 
[presumptive fibroblasts] and in individual differentiating 
ectomesenchymal cells (pdlfb) o f the periodontal ligament. Also note 
that the dentin (d), predentin (pd) and the region of future cementum (c) 
formation next to the dentin layer do not show immunolocalization of 
FGF-2. Counterstained with Meyer’s haematoxylin. Bar: 10 pm. 
Representative section of the developing root o f a maxillary first molar 
of a 16-day post-natal mouse pup. Note immunolocalization of FGF-2 in 
the odontoblasts (od), in individual cementoblasts (cb), in a few 
differentiating ectomesenchymal cells (pdlfb) of the periodontal ligament 
and in the presumptive osteoblasts (dob). Counterstained with Meyer’s 
haematoxylin. Bar: 20 pm.
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3.5 Immunolocalization of FGF-2 in the root of the murine tooth on post-natal 
day 20
On post-natal day 20, routinely stained haematoxylin and eosin sections showed the 
eruption o f the second molar in both the arches. Enamel maturation and progress in root 
formation was evident in the third molar. The process o f cementogenesis was noted with 
the formation o f the zone o f cementum next to the dentin layer (Fig. 19). Neither 
ameloblasts nor the stratum intermedium was present.
The presence o f various tissues and cell types as noted in Table 3.5 were obvious in the 
molars and incisors.
In general, at this stage, as seen in Table 3.5 and Figs. 20, 21 and 22, 
immunolocalization o f FGF-2, both in the maxillary and mandibular molars and incisors 
was evident in the nucleus and cytoplasm of the odontoblasts, differentiating 
ectomesenchymal cells (presumptive fibroblasts) in the pulp chamber and in the 
developing periodontal ligament, presumptive osteoblasts lining the developing alveolar 
bone and in the presumptive cementoblasts in the zone o f cementum formation next to 
the dentin layer.
Intense localization o f FGF-2 was observed in the cytoplasm and the nucleus o f the 
odontoblasts in the apical part of the root as compared to those placed more coronally 
(Figs. 20 and 21).
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Expression o f FGF-2 was again evident in the cytoplasm of many differentiating 
ectomesenchymal cells [presumptive osteoblasts] (Fig. 22).
Not all, but a few differentiating ectomesenchymal cells (i.e. presumptive 
cementoblasts) around the zone o f cementum formation also expressed FGF-2 (Figs. 20 
and 21).
The dentin (Figs. 20 and 21), the predentin (Figs 20 and 21) and the zone of cementum
formation (Fig. 20) showed no localization of the antibody.
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Expression o f FGF-2 was again evident in the cytoplasm of many differentiating 
ectomesenchymal cells [presumptive osteoblasts] (Fig. 22).
Not all, but a few differentiating ectomesenchymal cells (i.e. presumptive 
cementoblasts) around the zone o f cementum formation also expressed FGF-2 (Figs. 20 
and 21).
The dentin (Figs. 20 and 21), the predentin (Figs 20 and 21) and the zone o f cementum
formation (Fig. 20) showed no localization of the antibody.
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Table 3.5 Immunolocalization of FGF-2 in the root of the murine tooth 
on post-natal dav 20
Mandibular
■ 'i
: ■ V" . . '•
Central First Second Third First Second Third
Incisor Molar Molar Molar Molar Molar Molar
Stratum intermedium (si) A A A A A A A
Ameloblasts (am) A A A A A A A
Odontoblasts (od) + + + + + + +
Differentiating 
ectomesenchymal cells 
(dmc)
+ + + + + + +
Predentin (pd) - - - - - - -
Dentin (d) - - - - - - -
Zone of Cementum (c) - - - - - - -
Differentiating 
ectomesenchymal cells in 
the cementum zone (cb)
+ + + + + + +
Differentiating 
ectomesenchymal cells 
lining the developing 
alveolar bone (dob)
+ + + + + + +
Differentiating 
ectomesenchymal cells in 
the pulp chamber (dfb)
+ + + + + + +
Differentiating 
ectomesenchymal cells of 
the periodontal ligament 
(pdlfb)
+ + + + + + +
Legends:
(+): Positive for immunoreactivity for FGF-2
(-): Negative for immunoreactivity for FGF-2
(A): Absent at this stage
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Figure 19
Figure 20
Representative section o f the developing mandibular first molar o f a 20- 
day post-natal mouse pup. Note the presence o f dentin (d), odontoblasts 
(od), developing periodontal ligament (pdl), developing alveolar bone 
(avb), the zone of cementum (c) formation and the differentiating 
ectomesenchymal cells (dfb) [presumptive fibroblasts] o f the pulp 
chamber and canal. Haematoxylin and eosin stain. Bar: 50 pm.
Representative section o f the developing root o f a mandibular second 
molar o f a 20-day post-natal mouse pup. Note immunolocalization of 
FGF-2 in the odontoblasts (od), in a few differentiating 
ectomesenchymal cells (dfb) [presumptive fibroblasts] and in the 
presumptive cementoblasts (cb). Note that the dentin (d), predentin (pd) 
and the zone of cementum (c) formation next to the dentin layer do not 
show immunolocalization of FGF-2. Counterstained with Meyer’s 
haematoxylin. Bar: 10 pm.
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Figure 21 Representative section of the developing root o f a mandibular first molar 
o f a 20-day post-natal mouse pup. Note the immunolocalization of 
FGF-2 in the odontoblasts (od), in the differentiating ectomesenchymal 
cells (cb) in the zone o f cementum formation [presumptive 
cementoblasts] and in differentiating ectomesenchymal cells (dfb) of the 
pulp canal [presumptive fibroblasts]. Note that the dentin (d) and 
predentin (pd) show no localization o f the antibody. Counterstained with 
M eyer’s haematoxylin. Bar: 10 pm.
Figure 22 Representative section of the developing alveolar bone and the 
periodontal ligament of a mandibular first molar of a 20-day post-natal 
mouse pup. Note the immunolocalization of FGF-2 in the differentiating 
ectomesenchymal cells (dob) [presumptive osteoblasts] lining the 
developing bone (avb) and in few differentiating ectomesenchymal cells 
(pdlfb) [presumptive fibroblasts] of the periodontal ligament. 
Counterstained with Meyer’s haematoxylin. Bar: 20 pm.
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3.6 Immunolocalization of FGF-2 in the root of the murine tooth on post-natal 
day 24
Root development in the first and second molar was almost complete by post-natal day 
24. Odontoblasts, dentin, predentin, differentiating ectomesenchymal cells in the 
different parts of the developing root (presumptive odontoblasts and fibroblasts) and 
osteoblasts as well as the zone o f cementum formation were obvious as seen in the 
previous two stages i.e. post-natal days 16 and 20 (Fig. 23).
Sections treated with the immunocytochemical procedure for FGF-2 demonstrated the 
same pattern of immunoreactivity in the molars and incisors, as observed in the previous 
stage (see Table 3.6 and Figs. 24 and 25). Intense homogeneous localization of FGF-2 
was seen in the cytoplasm and nucleus of the odontoblasts (Figs. 24 and 25) and in 
differentiating ectomesenchymal cells (presumptive odontoblasts) in the developing root 
(Figs. 24 and 25).
Presumptive cementoblasts, in the developing periodontal ligament and presumptive 
osteoblasts lining the developing bone also exhibited localization o f the antibody in the 
nuclei and extracellular matrix (Figs. 24 and 25).
The differentiating ectomesenchymal cells of the pulp chamber (dfb) and of the 
periodontal ligament (pdlfb) were also immunoreactive to this protein (Fig. 25)
Once again, no immunolocalization occurred in the dentin, the predentin and in the zone 
o f cementum formation (Fig. 25).
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Table 3.6 Immunolocalization of FGF-2 in the root of the murine tooth 
on post-natal day 24
Maxillary •- ■ C’i  •' • •'* ' ’ •*.* ***i£’H i • . :r /. - ■.
•V Mandibular
^  v ,Central
Incisor
First Second• • . S’*./ r
Molar Molar
Third
Molar
' • • " > 
First 
Molar
Vv^jO:.v ",v:, • /,
Second
Molar
Third
Molar
Stratum intermedium (si) A A A A A A A
Ameloblasts (am) A A A A A A A
Odontoblasts (od) + + + + + + +
Differentiating + 
ectomesenchymal cells 
(dmc)
+ + + + + +
Predentin (pd) - - - - -
Dentin (d) - - - - -
Zone of Cementum (c) - - - - -
Differentiating + 
ectomesenchymal cells in 
the cementum zone (cb)
+ + + + + +
Differentiating + 
ectomesenchymal cells 
lining the developing 
alveolar bone (dob)
+ + + + + +
Differentiating + 
ectomesenchymal cells in 
the pulp chamber (dfb)
+ + + + + +
Differentiating + 
ectomesenchymal cells of 
the periodontal ligament 
(pdlfb)
+ + + + + +
Legends:
(+): Positive for immunoreactivity for FGF-2
(-): Negative for immunoreactivity for FGF-2
(A): Absent at this stage
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Figure 23
Figure 24
Figure 25
Representative section of the developing mandibular first molar of a 24- 
day post-natal mouse pup. Note the presence o f dentin (d), odontoblasts 
(od), developing periodontal ligament (pdl), developing alveolar bone 
(avb) and the differentiating ectomesenchymal cells (dfb) of the pulp 
[presumptive fibroblasts]. Haematoxylin and eosin stain. Bar: 50 pm.
Representative section of the developing root o f a mandibular third molar 
o f a 24-day post-natal mouse pup. Note immunolocalization o f FGF-2 in 
the odontoblasts (od), in the differentiating ectomesenchymal cells (dmc) 
in the root region [presumptive odontoblasts], in the ectomesenchymal 
cells (cb) in the zone of cementum formation [presumptive 
cementoblasts] and in a few differentiating ectomesenchymal cells 
(pdlfb) [presumptive fibroblasts] o f the periodontal ligament. 
Counterstained with Meyer’s haematoxylin. Bar: 10 pm.
Representative section of the developing root o f a mandibular first molar 
o f a 24-day post-natal mouse pup. Note immunolocalization of FGF-2 
in the odontoblasts (od) in the root region, in the differentiating 
ectomesenchymal cells (cb) [presumptive cementoblasts] in the zone 
where cementum will form and in a few presumptive fibroblast of the 
pulp canal (dfb) and in periodontal ligament (pdlfb). Counterstained with 
Meyer’s haematoxylin. Bar: 20 pm.
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3.7 Summary of the Results
Immunocytochemical localization of FGF-2 was seen in the cytoplasm, nucleus and in 
the extracellular matrix o f the various tissues and cell types of the root at different times 
o f development o f the teeth.
To summarize, the ameloblasts were present on post-natal days 9 to 12, after which they 
started degenerating. While present, localization of the antibody was seen in almost all 
of the cells. The cytoplasm in general was immunoreactive at these stages, while the 
nuclei o f some cells also demonstrated affinity for FGF-2. With development, 
expression o f FGF-2 progressed from the crown region to the apical part of the teeth. 
On post-natal day 12, the intensity of localization o f FGF-2 antibody seemed to be 
decreased in most o f the ameloblasts (Fig. 15) as compared to the previous two stages of 
development i.e. post-natal days 9 and 10.
In the odontoblast layer, which was present at all stages examined, homogeneous 
localization o f the antibody was observed in the cytoplasm of most of the cells. 
Intensity o f the FGF-2 appeared to be increased in the cells developing apically at all 
the stages, although this was not quantified. However, specific mention should be made 
to the presumptive odontoblasts in the apical region of the developing root that 
demonstrated nuclear immunoreactivity for FGF-2, in addition to the cytoplasmic
affinity.
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On post-natal days 9, 10 and 12, only a few differentiating ectomesenchymal cells 
(presumptive odontoblasts, fibroblasts and osteoblasts) from the dental papilla and 
dental follicle were immunoreactive for the antibody, and demonstrated more nuclear 
affinity. With progression in development at later stages i.e. on post-natal days 16, 20 
and 24, many cells o f the same type were immunoreactive to FGF-2.
The dentin demonstrated a faint “discoloration” at 9 and 10 days postnatal. In the later 
stages i.e. post-natal days 12, 16, 20 and 24, discoloration o f the dentin did not occur.
The stratum intermedium, which was present until postnatal day 12, showed no 
evidence o f immunolocalization at any stage. The predentin, was similarly negative for 
FGF-2 at all the stages examined.
When the process o f cementogenesis started on post-natal day 16, a few differentiating 
ectomesenchymal cells (presumptive cementoblasts) next to the dentin layer, exhibited 
immunolocalization. This continued on post-natal days 20 and 24.
At all the stages examined i.e. post-natal days 9, 10, 12, 16, 20 and 24, condensed 
differentiating ectomesenchymal cells in the area of root development and the 
presumptive furcation zone exhibited nuclear affinity for FGF-2 protein.
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CHAPTER 4
4.0 DISCUSSION
4.1 General
Tooth development is an excellent example of a system in which the mechanisms of early 
epithelio-mesenchymal interactions and molecular signaling can be studied (Vaino et al., 
1993; Chen et al., 1996; Vaahtokari et al., 1996; Neubiiser et al., 1997; Thesleff and 
Sharpe, 1997). It is believed that the same conserved signaling molecules such as fibroblast 
growth factors (FGF’s), bone morphogenetic proteins (BMP’s), Hedgehog genes (Hh) and 
Wnt family members mediate the inductive interactions between the epithelium and 
mesenchyme (Pispa et al., 1999). These signaling molecules regulate the development of 
vertebrate organs such as the teeth, the hair and the glands. The present study has 
investigated the pattern of expression of fibroblast growth factor-2 (FGF-2), in the different 
cell types and tissues of the developing root of murine teeth (first, second and third molars 
and incisors) at various stages of development.
Appropriate controls such as the positive, negative and absorption (peptide neutralization) 
controls were used for the immunocytochemistry. Sections of the submandibular gland of 
an adult rat were used as a positive control, in which localization of FGF-2 in the epithelial 
cells lining the striated and excretory ducts and granular convoluted tubules had been 
previously demonstrated (Amano et al., 1993). In the present study, results of the positive 
control were the same as described by Amano et al. (1993). For the negative controls, 
sections adjacent to the section on which FGF-2 had been localized were utilized. Minimal 
or no background staining was observed in these sections. For the absorption control,
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sections of the tooth adjacent to a section depicting the localization of the antibody were 
incubated with a solution of pre-absorbed antibody and antigen (1:5 incubated overnight at 
4° C) substituted for the primary antibody. Once again minimal or no background staining 
was observed in these sections. This confirmed that, indeed, the primary antibody is 
responsible for immunolocalization in the test sections.
Consistency of localization of FGF-2 (thus attesting to antibody binding) was noted 
throughout the serial sections examined within each of the age groups and at all the stages 
examined. With progression in root development apically, spatial and temporal differences 
in the expression of FGF-2 in some cell types and tissues were noted. This may be due to 
differences in the stages of root morphogenesis. Some cells/tissues e.g. ameloblasts, 
disappeared while some cell types (of ectomesenchymal origin) e.g. presumptive 
odontoblasts, osteoblasts and fibroblasts, differentiated from the dental papilla and dental 
follicle as time progressed. However, the pattern of immunolocalization for all cell types 
studied was consistent for both the mandibular and the maxillary molars and the incisors at 
all the six stages examined.
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4.2 Differential localization of FGF-2 in the cytoplasm and nucleus, and in the 
extracellular matrix
Immunolocalization of FGF-2 occurred in both parts of the different cell types and tissues 
namely the cytoplasm and nucleus at different times of development. Cell types and tissues 
included ameloblasts, odontoblasts, dentin and the differentiating ectomesenchymal cells 
(presumptive odontoblasts, osteoblasts, fibroblasts and cementoblasts) from the developing 
dental follicle and the dental papilla.
Some evidence of localization in the extracellular matrix of different cell types was also 
observed. Recent advances in techniques have helped developmental biologists to 
understand the protein chemistry and molecular cloning of this family of growth factors. 
Several studies have elucidated that FGF-2 in mice and humans occurs in four isoforms: a 
low molecular weight [LMW FGF-2, 18 KDa] isoform and three high molecular weight 
[HMW FGF-2, 22, 22.5 and 24 KDa] isoforms (Amaud et al., 1999; Delrieu, 2000; Nugent 
and Iozzo, 2000; Omitz, 2000). These different isoforms are generated as a result of 
initiation of alternative translational sites within a single mRNA species (Amaud et al., 
1999). In the present study, an antibody to FGF-2 was used that has a molecular weight of 
17 KDa as per the literature supplied by the manufacturer. This belongs to the low 
molecular weight isoform of FGF-2. The predominant form of FGF-2 is an 18 KDa protein 
that is formed due to initiation at the AUG codon (Abraham et al., 1986). However, 
proteolytic cleavage of the first nine amino acids of this form may even produce shorter 
forms such as 16 KDa and 17 KDa, which are as active as the 18 KDa form (Klagusbrun et 
al., 1987). It is believed that the low molecular weight isoform is expressed in the 
cytoplasm and in the extracellular matrix and primarily functions in an autocrine manner.
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However, the recent studies of Arese et al. (1999) have shown that due to common amino 
acid sequence of low and high molecular weight isoforms, LMW FGF-2 is capable for 
modulation of low serum growth and thus may also act as a biological messenger in both 
the autocrine/paracrine and intracrine pathways.
On the other hand, the three high molecular weight isoforms are formed due to translation 
that initiates at CUG codons 5’ to the AUG codon. This translation results in two functional 
domains of HMW isoforms: a complete amino acid sequence of the 18 KDa form and N- 
terminal extensions of varying lengths. These isoforms are supposed to have a preferential 
affinity for the nucleus and exert their activities through intracrine, perhaps nuclear, 
pathways (Arese et al., 1999).
4.2.1 Nuclear localization of FGF-2
In the present study, localization of the 17 KDa (LMW) isoform occurred in the nuclei of 
various cell types. Although the scientific literature has tried to elucidate the affinity of 
FGF-2 for the nucleus, the complete mechanism of the actions occurring at cellular and 
sub-cellular levels is yet to be understood.
It is believed that the members of fibroblast growth factor family mediate their effects via 
membrane bound receptors (Basilico and Moscatelli, 1992; Klint et al., 1999). But not all 
of the effects of cellular messengers may be produced in this manner. It is suggested that 
there exists a direct association of growth factors, namely platelet derived growth factor 
(PDGF), fibroblast growth factor (FGF), nerve growth factor (NGF), epidermal growth
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factor (EGF) and neuro- transmitters or cytokines, with the cell nucleus (Mason, 1994; 
Wiedlocha et al., 1996; Choi et al., 2000).
To address the issue of nuclear affinity of FGF-2, Bouche et al. (1987) and Baldin et al. 
(1990) have reported that when low molecular weight (18 KDa) FGF-2 is added 
exogenously to synchronized cultures of bovine aortic endothelial cells (ABAE), this 
protein translocates and accumulates in the nucleolus during the G0/G1 transition cycle and 
remains upgraded for up to 6 hours. They also observed that up to 50% of total internalized 
FGF-2 is rapidly targeted to the nucleus in coronary venular endothelial cells. They 
believed that this nuclear uptake is controlled by the cell cycle, as this was specific only for 
the late G1 phase of the cell cycle whereas cytoplasmic uptake occurs throughout the cell 
cycle (Baldin et al., 1990). On the basis of their work, it was suggested that some of the 
biological activities of this growth factor might be modulated by nuclear FGF-2, after it 
binds to the cell surface receptors.
In line with the above work, immunofluorescence studies of Tessler and Neufeld (1990), 
with FGF-2 antibody have demonstrated that FGF-2 exhibits intense nuclear affinity for 
various endothelial cells known to produce FGF-2 and, in addition, in FGF-2 transfected 
BHK cells.
Dono and Zeller (1994) have shown that FGF-2 protein expresses in the nuclei of the post­
mitotic, terminally differentiating cells during chicken lung morphogenesis. In the
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latter study they identified synthesis of three isoforms of FGF-2 by alternate translation 
initiation. They suggested that out of three isoforms, the low molecular weight isoform 
signals through the FGF receptor, and is internalized to the nucleus of the responding cells. 
However, none of these studies provide a satisfactory mechanism to understand the 
functional aspect of the localization of this growth factor to the nucleus.
To address the nuclear localization of FGF-2, two mechanisms have been put forward:
(1) Internalization of the extracellular 18 KDa FGF-2 isoform.
(2) Preferential nuclear localization of the high molecular weight FGF-2 isoform.
The high molecular weight isoforms are known to contain functional nuclear localization 
signals (NLSs), whereas the 18 KDa isoforms do not. However, both 18 KDa FGF-2 (low 
molecular weight) and 24 KDa FGF-2 (high molecular weight) isoforms are capable of 
binding non-specifically and with high affinity to nuclear chromatin. This is due to the fact 
that sequences within the 18 KDa protein, but not the amino-terminal extension, are 
necessary for this binding. This is substantiated by the fact that FGF receptor-1 (FGFR-1) 
also, which is believed to be the most effective receptor for FGF-2, translocates to the 
nucleus following internalization. In addition, it is shown that neither the ligand nor the 
receptor contains a nuclear localization signal (NLS). Nuclear import and the definitive 
function of this receptor in this cascade were not proven. Recently, however, Reilly and 
Maher (2001) described that nuclear translocation of FGFR-1 occurs via a mechanism 
distinct from classical nuclear, import but dependent upon importin |3, a component of 
multiple nuclear import pathways.
Chapter four- Discussion 71
Another proposal to describe the nuclear localization of the low molecular weight isoform 
(18 KDa) states that this event correlates with the stimulation of ribosomal gene 
transcription, whose activation is mediated via the direct interaction of nuclear FGF-2 with 
the regulatory subunit of the protein kinase CKII (Bonnet et al., 1996).
To further elaborate this aspect of nuclear localization of LMW FGF-2, Arese et al. (1999) 
using contemporary techniques like cell culture, FGF-2 cDNA mutation, 
immunocytochemistry, western blot analysis, (3 -Galactosidase activity assays and BrdU 
incorporation analysis demonstrated that when LMW FGF-2 is artificially fused to a 
canonical nucleus localization signal (NLS) and targeted to a nucleus in NIH-3T3 cells, it 
mimics the effects of HMW FGF-2 on low serum growth. This finding supports the 
concepts that nuclear activity of HMW is due to sequences it shares with LMW FGF-2. 
Two separate signals, the amino-acid terminal extension of HMW and a particular 
nucleolar localization sequence within the LMW sequence, are needed for nuclear 
topogenesis of FGF-2.
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4.2.2 Localization of low molecular weight FGF-2 in the cytoplasm and extracellular 
matrix
Sub-cellular distribution of the four forms of FGF-2 has been examined in different cells 
which over-express FGF-2, as well as in the non-transfected endothelial, neuronal and 
neuro-endocrine cells using both immunocytochemistry and sub-cellular fractionation 
techniques (Rento et al., 1990; Bugler et ah, 1991; Yu et al., 1993; Stachowiak et al., 
1994).
Regarding the localization of low molecular weight isoforms of FGF-2 in the cytoplasm 
and in the extracellular matrix, it is proposed that the complex genetic organization of both 
FGF ligand and receptors present a great number of regulatory mechanisms to mediate the 
biological effects of this extensive family of growth factors. These biological effects of 
FGF’s (ranging from proliferation and apoptosis to migration and differentiation) are 
mediated through four high affinity transmembrane kinase receptors, known as fibroblast 
growth factor receptor 1-4 [FGFR-1 to FGFR-4] (Basilico and Moscatelli, 1992; Klint et 
al., 1999). These FGFR’s structurally resemble other transmembrane kinase receptor and 
their presence in all contemporary vertebrates is documented (Coulier et al., 1997). These 
receptors are believed to initiate the signaling cascade after binding with the cell surface 
and thus mediate gene expression in the nucleus (Stachowiak et al., 1994).
As documented in the literature, two FGF-receptor (FGF-R) binding sites (of high and low 
molecular affinity) on FGF-2 are believed to act in concert to initiate signal transduction 
(Springer et al., 1994). These sites are known to be distinct from the heparan sulfate
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proteoglycans-binding domain. The high affinity binding sites consist of a solvent exposed 
hydrophobic amino acids cluster (Tyr-24, Tyr-103, Leu-140 and Met-142) and provide 
75% of binding affinity and dominate the primary binding interactions. The low affinity 
binding sites are composed of amino acids (Lys-110, Tyr-111 and Trp-114) and participate 
in the secondary binding [which is 250-fold lower in affinity than primary interaction] 
(Springer et al., 1994). It has been determined that the residues that constitute the primary- 
receptor binding site of FGF-2 are conserved throughout the FGF family, whereas those of 
secondary binding sites of FGF-2 are not (Springer et al., 1994). It is suggested that 
“variable” secondary sites on both FGF as well as FGFR mediate specificity of a given 
FGF to a given FGFR isoform. The receptors that are monomeric in their native state 
dimerize after binding with an FGF ligand. This dimerization activates tyrosine kinase and 
triggers downstream effects through multiple signaling pathways (Springer et al., 1994).
In the above proposed model of FGF-FGFR, the two domains of a single FGFR wrap 
around a single FGF-2 molecule such that one domain of FGFR binds to the primary 
receptor binding site of the FGF molecule, while the second domain of the same FGFR 
binds to the secondary receptor binding site of the same FGF molecule. This binding of 
FGFR to both FGF-2 surfaces is said to promote growth factor-mediated cell proliferation. 
This model compensates for not only heparin-like glycosaminoglycan (HLGAG) 
interactions with FGF and FGFR, but also FGF dimerization or oligomerization mediated 
by HLGAG (Venkataraman et al., 1999).
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In addition to the binding of low molecular weight isoform of FGF-2 with high-affinity 
FGFR’s, localization of FGF-2 in the extracellular matrix may also occur through its 
binding with heparin sulfate proteoglycans (HSPG’s) as well as to a low-affinity, cysteine- 
rich transmembrane FGF-binding protein (Zhou et al., 1997). These HSPG’s are sulfated 
glycosaminoglycans bound to a core protein, which is localized in the extracellular matrix 
and are believed to provide a storehouse for FGF-2 in this location. This mechanism not 
only provides the gradual bioavailability of FGF-2 in response to the internal or external 
stimuli, but also protects FGF-2 from degradation.
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4.3 Immunolocalization of FGF-2 in the odontoblasts and presumptive 
odontoblasts
In the present study, consistent and uniform expression of FGF-2 was noted in the 
cytoplasm of most of the odontoblasts from post-natal days 9 to 24. A nuclear affinity for 
this protein was also noted in some odontoblasts at all the stages examined. On post-natal 
day 9, when the formation of the root had not yet begun in most of the teeth, odontoblasts 
located in the crown region of all the teeth were immunoreactive to FGF-2. With the onset 
of root formation from post-natal day 10, odontoblasts in the root region started 
differentiating. This process continued until the mature length of the root was observed, in 
most of the teeth, by post-natal day 24. Concurrent with progressive odontoblast 
differentiation, FGF-2 immunoreactivity appeared to progress from the cervical to the 
apical region of the developing root. Specific mention should be made of the differentiating 
ectomesenchymal cells (presumptive odontoblasts) of the developing root. These cells 
exhibited specific nuclear affinity for this protein at all the stages examined. It has been 
shown that nuclear localization of FGF-2 is specific for the late G1 phase of the cell cycle 
as described in section 4.2.1 (Baldin et al., 1990). In the present study, this may account for 
the localization of FGF-2 in the nuclei of the presumptive odontoblasts with their 
successive differentiation from the ectomesenchymal cells of the dental papilla.
Previous studies using immunocytochemical techniques by Cam et al. (1992) and Russo et 
al. (1997) have reported expression of FGF-2 in the cytoplasm of the odontoblasts in early 
tooth morphogenesis. These pre-natal developmental studies were carried out in mice up to 
day 18 of the embryonic stage (E l8). Cam et al. (1992) and Russo et al. (1997) 
demonstrated that FGF-2 expression in the cytoplasm of the odontoblasts is first evident at
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the cap stage and continues until the late bell stage, with intense localization of this growth 
factor in the late bell stage of the developing crown. These investigators suggested that 
FGF-2 might be involved in the control of polarization and differentiation of the 
odontoblasts. They have also reported the expression of FGF-2 in the dental basement 
membrane and the stellate reticulum in early stages of odontogenesis. It is possible that 
expression of this growth factor in the structures of epithelial origin may play a role in the 
sequential events of the epithelio-mesenchymal interactions in the developing crown. Also, 
Unda et al. (2000) have shown that FGF-2 and FGF-receptors (FGFR) are expressed in the 
basement membrane in the early bell stage (E-17) of molars, and have assigned a role to 
FGF-2 in cell polarization. In addition, it is established that transcripts of the FGF 
receptor-1 (FGFR-1 also called fig) are detected in the odontoblasts (Orr-Urtreger et al., 
1991; Peters et al., 1992) and recently the IIIc splice form of FGFR-1, which binds FGF-1 
and FGF-2, has been found in the dental epithelium, pre-odontoblasts and differentiated 
odontoblasts (Kettunen et al., 1998). Studies by Lesot et al. (1992) and Tziafas et al. (1992) 
also support localization of -FGF-2 in the odontoblasts. These investigators have 
demonstrated that fibronectin (a component of the extracellular matrix) plays a role in the 
induction of odontoblast differentiation. FGF-2 is proposed to bind to type-IV collagen, 
laminin and fibronectin.
FGF-2 may play a similar role in odontoblast differentiation in root development. In vitro 
and in vivo studies have shown that the process of odontoblast differentiation is a key 
feature in root morphogenesis (Ruch, 1985). This comprises of sequential and highly 
integrated mechanisms that involve a series of cytological and functional changes. This 
cascade of events mediates sequential interactions of pre-odontoblasts with the adjacent
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inner dental epithelium, through the specific basement membrane (Thesleff et al., 1996; 
Thesleff and Nieminen, 1996; Thesleff and Sharpe, 1997; Avery, 2001). Reciprocally, the 
inner dental epithelium promotes the terminal differentiation of the pre-odontoblasts into 
post-mitotic, cytologically differentiated odontoblasts (polarized odontoblasts). Newly 
secreted extracellular matrix at the epithelio-mesenchymal interface plays an important role 
in this interaction. This is followed by terminal differentiation (i.e. cytoplasmic 
polarization, including changes in the distribution of microtubules, microfilaments and 
intermediate elements) of odontoblasts. Finally, odontoblasts become fully differentiated in 
structure and function and secrete the components of the predentin and dentin at their apical 
pole (Ruch 1998).
The importance of many growth factors either at the mRNA level or protein level that may 
play a critical role in the onset of odontoblast differentiation has been elucidated. These 
include: FGF-1 and FGF-2 (Cam et al., 1992), IGF-I and -II (Martin et al., 1998), PDGF 
(Chai et al., 1998) and polypeptides belonging to the transforming growth factor-p (TGF-P) 
superfamily, which include BMP-2, -4, -6, and -7 (Cam et al., 1990; D ’Souza et al., 1990; 
Heikinheimo et al., 1997; Thomadakis et al., 1999). It is observed that these growth factors 
and/or their mRNA transcripts, demonstrate a specific pattern of localization both spatially 
and temporally. Based on this specificity, these studies have suggested that these growth 
factors may play a role in odontoblast differentiation.
It is believed that synergistic interactions between members of different families of growth 
factors mediate the cascade of events for the induction of proliferation and differentiation in
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different cell types and organs (Frenz et al., 1994 and Li et al., 2000). No single 
“standalone” growth factor can undertake this mammoth task. This fact holds true for FGF- 
2. Studies by Martin et al. (1998) has shown that the culture of the dental papilla of the 
mandibular first molar, treated with FGF-2 alone induces cell polarization at the periphery 
of the explants. This FGF-2 induced polarization occurs in the restricted areas 
corresponding to the cusps with no accumulation of extracellular matrix. However, FGF-2 
in combination with transforming growth factor P-1 (TGFp-1) and insulin like growth 
factor-I (IGF-I) induces intense cell polarization. Since TGFp-1 alone has not been shown 
to be capable of promoting cell differentiation in dental papillae cultured in vitro (Unda et 
al., 2001), the inductive effect may be attributed to synergistic and specific interactions 
between TGF P-1 with FGF-2.
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4.4 Immunolocalization of FGF-2 in the cementoblasts, periodontal ligament and 
alveolar bone
The present study has reported the localization of FGF-2 in the differentiating 
ectomesenchymal cells of the periodontal ligament. These included the presumptive 
cementoblasts located in the innermost part of the ligament, presumptive fibroblasts of the 
periodontal ligament located centrally and presumptive osteoblasts lining the developing 
alveolar bone in the outermost part, in relation to the developing root.
4.4.1 Immunolocalization of FGF-2 in presumptive cementoblasts
On post-natal days 16, 20 and 24, the presence of presumptive cementoblasts was noted 
along the coronal-to-apical gradient of the root. This coincides with the time when the 
process of cementogenesis begins in the mouse root. Cho and Garrant (1988) have 
suggested that these cementoblast precursors arise from the ectomesenchymal cells of the 
dental follicle and migrate towards the root dentin surface following disruption of the 
intervening epithelial root sheath. Immunolocalization of FGF-2 was observed in the 
cytoplasm and nuclei of the cementoblasts at all stages of presence. Expression was evident 
in some of the cells. This may be due to the different stages of differentiation of the 
cementoblasts from the dental follicle and may vary with the time of “recruitment” of the
cells from the follicle.
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The presence of FGF-2 in the fibroblasts of mature human periodontal ligament is well 
documented in the literature (Gao et al., 1996). This may support the expression of this 
growth factor in the presumptive cementoblasts also, as both are of the same embryonic 
origin. Murakami et al. (1999; 2003) have suggested that local application of FGF-2 in 
experimental models increases the number of undifferentiated mesenchymal cells of the 
periodontal ligament. These undifferentiated mesenchymal cells differentiate into 
cementoblasts and osteoblasts and thus induce the process of cementogenesis and 
osteogenesis. Thus, the presence of FGF-2 in the developing root suggests that this growth 
factor may play a role in the differentiation of cementoblasts.
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4.4.2 Immunolocalization of FGF-2 in presumptive fibroblasts of the periodontal 
ligament
The periodontal ligament (PDL) develops from the central layer of the dental follicle 
shortly after root development is initiated (Ten Cate, 1998). The development and 
maturation of the PDL is dependent on the formation of the root dentin and the synthesis of 
its investing mineralized tissue, the cementum. Fibroblasts are the most predominant cells 
of the PDL. They synthesize and remodel extracellular matrices that include collagen fibres 
and a large component of the nonfibrillar glycoproteins. They play an important role in the 
development, structure and function of the supporting apparatus of the tooth (Ten Cate, 
1998).
In the present work, immunolocalization of FGF-2 was detected in the cytoplasm and 
nucleus of some presumptive fibroblasts of the periodontal ligament (PDL), as well as in 
the extracellular matrix (ECM) at all the stages examined. Fibroblasts were identified on 
the basis of their morphology by light microscopy. Localization of FGF-2 progressed in 
many fibroblasts with progression in root development.
On post-natal day 9, only a few differentiating ectomesenchymal cells of the periodontal 
ligament (presumptive fibroblasts) were immunoreactive. The expression of FGF-2 was 
concentrated more in the nuclei than in the cytoplasm of these cells. This probably was due 
to the internalization of FGF-2 in the nuclei during the early stage of the cell cycle as 
described in section 4.2.1. With progression in the development of the periodontal 
ligament from post-natal days 10 to 24, many differentiating presumptive fibroblasts in the
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same region demonstrated the affinity for FGF-2 in the cytoplasm and in the nucleus, as 
well as in their extracellular matrix.
Expression of FGF-2 in the cytoplasm and nucleus as well as in the extracellular matrix is 
well documented in the literature. Aktas and Kayton (2000) reported cytoplasmic and 
nuclear expression of FGF-2 in fibroblasts of the adrenal gland and kidney of adult rats and 
in the human lung and dermal tissue in normal healthy conditions. Using pre-embedding 
labeling methods, expression of FGF-2 in fibroblasts and in the extracellular matrix has 
been reported by Ohtani et al. (1993) and Yabu et al. (1993). Another study by Gao et al. 
(1996) on mature human periodontal ligament has immunolocalized FGF-2 in the 
cytoplasm and extracellular matrix of the fibroblasts of the adult periodontal ligament i.e. in 
some fibrocytes, endothelial cells of the blood vessels and in the extracellular matrix. These 
authors have suggested that FGF-2 is released from fibroblasts and endothelial cells and is 
stored in the extracellular matrix (ECM) where it may have a role in the stimulation of 
fibroblasts. It was suggested that FGF-2 binds with the other components of the 
extracellular matrix, namely the basement membrane, collagen, fibronectin, glycoproteins 
and proteoglycans and may play a crucial role in cell adhesion, migration and morphology, 
differentiation and proliferation (Baum et al., 1980).
According to McNeil et al. (1989) and Clark et al. (1993), FGF-2 may be secreted from 
fibroblasts and transported to the extracellular matrix [which has been shown to be a 
storehouse for the bioactive form of FGF-2], These investigators suggest that endogenous
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FGF-2 released from fibroblasts to the ECM may result from cell lysis, as reported in 
endothelial cells, or secretion via a non-traditional mechanism. This feature of FGF-2 is 
attributed to the unusual property of this growth factor for lacking a signal peptide sequence 
(Mignatti et al., 1991).
Based on these studies, it is suggested this FGF-2 stored in the extracellular matrix may 
influence the proliferation and differentiation of the immature multipotent cells of the 
periodontium in the later stages of root development.
Takayama et al. (1997), using a cell culture technique, thymidine incorporation assay, 
reverse transcription polymerase chain reaction (RT-PCR) and an alkaline phosphatase 
(ALPase) assay, demonstrated the effects of FGF-2 on the cellular functions of PDL cells. 
Their studies have shown that FGF-2 induces the proliferation of PDL cells but inhibits the 
induction of ALPase activity in a dose dependent manner. In addition, FGF-2 enhances the 
synthesis of type-I collagen, which is one of the most common extracellular fibres in the 
periodontal ligament, and is essential for calcified nodule formation. Similar effects were 
observed on osteoblast cell lines. In addition, FGF-2 enhances the proliferative response of 
PDL cells in a dose-dependent manner in beagle dogs.
Recently, several polypeptide growth factors such as fibroblast growth factor-2 (FGF-2), 
transforming growth factor B-l (TGF 13-1) and bone morphogenetic protein-2 (BMP-2) 
have received attention as they regulate migration, attachment, proliferation and/or 
differentiation of the PDL cells (Terranova et al, 1987; Matsuda et al., 1992; Sigurdsson et
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al., 1995; Mohammed et al., 1998; Murakami et al., 1999). These factors may thus enhance 
the healing process by periodontal regeneration. The goal of PDL regeneration is to 
reconstitute the periodontal tissue onto a root surface. In this regenerative process, 
progenitor PDL cells need to migrate to the root surface, attach to it, proliferate and 
differentiate into an organized and functional fibrous attachment apparatus (Takayama et 
al, 1997).
The presence of FGF-2 in the developing root calls for further studies to investigate if this 
growth factor is present in the adult root. This may prove an important tool for PDL 
regeneration by employing recombination techniques. This suggestion is based on the 
findings that FGF-2 application is of great advantage for active induction of not only 
connective tissue regeneration, but also osteogenesis and cementogenesis (Murakami et al.,
1999).
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4.4.3 Immunolocalization of FGF-2 in presumptive osteoblasts
In the present study, immunolocalization of FGF-2 in the presumptive osteoblasts was 
evident at all the developmental stages studied i.e. from post-natal days 9 to 24. 
Localization of this growth factor was mainly in the cytoplasm with some evidence in the 
extracellular matrix, but some cells also demonstrated nuclear affinity for this protein. On 
post-natal day 9, most of the presumptive osteoblasts (which were recognized by their 
location around the surface of developing alveolar bone) were immunoreactive. With the 
progression of development, the number of FGF-2 positive cells surrounding the 
developing alveolar bone increased. This was probably due to the differentiation of more 
undifferentiated mesenchymal cells of the dental follicle at the surface of developing bone.
It is demonstrated that bone is a storehouse for growth factors that are capable of 
stimulating both osteoblast cell proliferation and differentiation (Hauschka et al., 1986; 
Ogawa et al., 1992). It has also been established that osteoblasts, which are responsible for 
bone formation, secrete a number of growth factors, namely fibroblast growth factors 
(FGF’s), transforming growth factor-P (TGF-P), bone morphogenetic proteins (BMP’s) and 
insulin-like growth factors (IGF’s). These secreted polypeptides are said to be mitogenic to 
bone cells in vitro (Hauschka et al., 1986).
Studies of FGF signaling in human and mouse have shown a pivotal role of this family of 
cytokines in the development of bone including growth, remodeling and repair. FGF family 
members control osteoblast gene expression in a biphasic fashion. However, conflicting 
reports on the exact nature of these effects exist in the literature. These differential effects
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of FGF’s depend upon the stage of osteoblast maturation (Rodan et al., 1989; Pitaru et al., 
1993; Liang et al., 1999; Mansukhani et al., 2000; Zeng et al., 2003).
In vitro studies have demonstrated that FGF-2 in particular, is capable of stimulating the 
proliferation of osteoblasts, chondrocytes and periosteal cells, and can also stimulate the 
formation of mineralized bone-like nodules in cultures of bone marrow stromal cells 
(Martin et al, 1997). It is believed that osteoblasts synthesize FGF-2 and store it in a 
bioactive form in the extracellular matrix (Rodan et al., 1989; Hurley et al., 1993).
Mansukhani et al. (2000) using a number of novel techniques namely immortalization of 
osteoblasts, DNA synthesis assays, alkaline phosphatase staining, apoptosis assay, 
immunoprecipitation and western blot analysis have shown that FGF-2 induces the 
proliferation of the immature phenotype of the osteoblasts. In the same context, it inhibits 
the proliferation of differentiating osteoblasts that are producing matrix and steadily 
upregulating alkaline phosphatase (ALP) and gradually promotes their apoptosis. Apoptosis 
results in repression of alkaline phosphatase (ALP) expression and further leads to the 
inhibition of DNA synthesis at a later time during differentiation. The main signaling 
cascade of FGF-2 responsible for cell proliferation and differentiation is known to be a 
RAS/MAP kinase dependent pathway (Klint et al., 1995; Kouhara et al. 1997). In addition, 
other pathways such as FRS2, Shp2, protein kinase C, cytoplasmic tyrosine kinase Src and 
protein kinase C-independent p 70S60 kinase are also suggested (Zhan et al., 1994; Kanda 
et al., 1997). Mansukhani et al. (2000) have shown that FGF signaling activates the FRS2, 
Shp2 and MAP kinase pathways in osteoblasts, while the STAT1 pathway is inhibited. It is 
suggested that during these pathways, differentiating osteoblasts could be expressing
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adapters or substrates that are different from those expressed in the immature phenotype 
and which could direct FGF signaling in novel, yet different pathways.
Mansukhani et al. (2000) also describe the dual role of FGF signaling in intramembranous 
ossification. It is thought that initially FGF stimulates the proliferation of immature 
osteoblasts, thus increasing the pool of osteoblast progenitors, and then acts as a “brake”. 
This would control the number of osteoblasts that undergo terminal differentiation. In 
addition, in vitro studies have shown that FGF-2 either stimulates or inhibits the production 
of type-I collagen (depending upon, the duration of FGF exposure and maturational stages 
of the cells being treated), the major differentiated product of osteoblasts (McCarthy et al., 
1989). Short term (24 h) treatment with FGF-2 resulted in the stimulation of the collagen 
gene (Hurley et al., 1993).
In contrast to the above studies, Debiais et al. (1998) have reported that FGF-2 reduces the 
expression of osteoblast markers in the less mature cells, while increasing osteocalcin 
production and matrix maturation in more mature cells. These observations indicate that 
FGF-2 may not have a consistent effect on osteoblast differentiation in vitro. This 
inconsistent effect of FGF-2 on osteoblast differentiation is attributed to the redundancy of 
FGF signaling. This is substantiated by the fact that the upregulated activation of FGF- 
signaling leads to bone morphogenetic defects namely achondroplasia and various 
craniosynostosis syndromes (McIntosh et al., 2000). However, overexpression of FGF-2 in 
transgenic mice results in premature mineralization, achondroplasia and shortening of long
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bones (Coffin et al., 1995) as well as the disruption of the FGF-2 gene that decreases the 
bone mass and bone formation (Montero et al., 2000).
Several studies have shown that FGF-2, while acting in concert with other growth factors, 
produces different effects at different developmental stages. Hanada et al. (1997) and 
Fujimura et al. (2002) using recombinant application of FGF-2 and BMP-2 in adult Wister 
rats have shown that low doses of FGF-2 with BMP-2 increase the osteoinductive activity 
(by inducing osteocalcin mRNA expression), while high doses result in inhibition of the 
activity. FGF-2 in synergism with TGF-{3 has also been shown to promote proliferation of 
chondrocytes and osteoblasts (Nakamura et al., 1995).
In line with the above investigations, it is believed that FGF-2 demonstrates strong anabolic 
effects (in the rat model), namely an increase in the number and activity of osteoblasts 
along the surfaces of cancellous and endochondral bone surface. This results in the 
accumulation of osteoid and the formation of cancellous and cortical bone mass. The 
anabolic effect of FGF-2 is also substantiated by in vivo treatment studies of fractured tibias 
in rabbits where it was shown that single injections of FGF-2 at 100 pg or above in a 3-mm 
bone defect results in increased volume and mineral content of the newly made bone after 5 
weeks (Kato et al., 1998). A similar model in dogs using FGF-2 (200 pg) also shows 
increased intramembranous ossification, osteoclast number in the periosteal callus and 
fracture strength (Nakamura et al., 1998; Kawaguchi et al., 2001).
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In the present study, localization of FGF-2 in osteoblasts, in successive morphogenetic 
stages of root development indicates that this growth factor may play a role in the 
differentiation of osteoblasts. It is possible that this growth factor may be deployed post- 
developmentally in regeneration of the alveolar bone if applied in low doses.
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4.5 Immunolocalization of FGF-2 in presumptive fibroblasts of the pulp
The present study demonstrates the immunolocalization of FGF-2 in presumptive 
fibroblasts of the pulp at important stages during the development of the root. Expression of 
FGF-2 was first evident in the cytoplasm and nucleus as well as in the surrounding 
extracellular matrix of presumptive fibroblasts of the pulp on post-natal day 9. With 
developmental progression and root elongation in the later stages i.e. from post-natal days 
10 to 24, many cells in this region showed the same pattern of expression of FGF-2.
The presence of FGF-2 in the presumptive fibroblasts of the pulp, in the present study, is in 
line with a previous study by Cam et al. (1992), who reported the presence of this growth 
factor in the dental papilla of the developing crown during the late bell stage (mouse). 
These investigators defined the expression of FGF-2 in successive morphogenetic stages of 
the tooth crown, but did not describe any functional role for FGF-2. In addition, in situ 
hybridization studies by Peters et al. (1992) have indicated the presence of FGF receptor-1 
(FGFR-l//7g) but not FGF receptor-2 (FGFR-2/Z>e&) [known to bind with FGF-2], in 
odontoblasts and in the underlying dental papilla in embryonic mice. However, they also 
could not co-relate the expression of FGFR-1 with its function. Thesleff et al. (1995) 
reported that FGF family members, including FGF-2 and FGF-receptors are co-expressed 
in the dental mesenchyme and dental epithelial cells when epithelio-mesenchymal signaling 
regulates the inductive events of tooth morphogenesis. Kettunen et al. (2000) using tissue 
recombination, bead experiments, in situ hybridization and cell proliferation assays have 
detected the presence of mRNA transcripts of two other members of the FGF family, 
namely FGF-3 and FGF-10, in the dental papilla of molars and incisors during early stages
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of mouse tooth odontogenesis. Kettunen et al. (2000) suggest that FGF-3 and FGF-10 are 
expressed when the differentiation of ectomesenchymal cells is regulated at the interface 
between the epithelium and mesenchyme. Niswander and Martin (1992) suggest that the 
members o f FGF family of ligands in general, play an important role in the control of 
proliferation, condensation and odontogenic differentiation of the dental mesenchymal cells 
by autocrine and paracrine mechanisms.
In the present work, expression of FGF-2 in some presumptive fibroblasts of pulp of the 
developing root may indicate that this growth factor is expressed at a time when the 
undifferentiated mesenchymal cells of the dental papilla become committed/determined to 
be presumptive fibroblasts, which are the predominant cell type of the pulp. In line with the 
previous documented work, it is possible that with initiation of differentiation of 
presumptive fibroblasts, FGF-2 and its receptors are expressed in these cell types and thus 
facilitate the cascade of events for differentiation.
Based on the expression of FGF-2, its related peptides and FGF-receptors in the 
mesenchymal cells of the dental papilla, several studies have suggested that this family of 
growth factor could be involved in the development and regeneration of the dentin, if 
employed therapeutically. These suggestions are based on findings that exogenous FGF-2 
added to cultured human pulp cells demonstrates higher levels of expression of 
osteonectin/SPARC (secreted protein, acidic and rich in cysteine) and SPARC transcripts (a 
major non-collagenous matrix protein in bone and dentin; abundant in the odontoblasts, but
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absent in the pulp cells) in the later stages, when the proliferation of the pulp cells is 
minimal. Also, this growth factor enhances alkaline phosphatase (ALPase) activity 
(Takano-Yamamoto et al., 1994; Unda et al., 2001). The marked expression of 
osteonectin/SPARC with increased alkaline phosphatase (ALPase) activity is believed to 
participate in the cascade of events that finally leads to the formation of dentin (Yoshiki 
and Kurahashi, 1971). These studies suggest that isolated pulp cells may be able to 
differentiate into odontoblasts in vitro when exposed to exogenous FGF-2.
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4.6 Immunolocalization of FGF-2 in the dentin
In the present work, faint discoloration of the dentin was observed on post-natal days 9 and 
10. In the later stages, no immunoreactivity in the dentin was observed at all. This 
immunolocalization, when it occurred was not convincing and definitive. It is possible that 
this may not be a tme immunoreactivity at these particular developmental stages, but rather 
background staining or immunolocalizarion of FGF-2 in odontoblastic processes extending 
into the dentin.
Previous work by Russo et al. (1997) reported an intense expression of FGF-2 in the dentin 
matrix in late bell stage [which corresponds approximately to embryonic day-20 (E-20)] of 
mouse tooth development. This coincides with the time when the odontoblasts begin 
secreting the dentin matrix. Their studies also indicate the presence of FGF-2 in 
differentiating odontoblasts during crown morphogenesis. However, these investigators did 
not explain the presence of FGF-2 in the dentin and its possible role therein. In their 
studies, it may be possible that FGF-2 present in the differentiated coronal odontoblasts is 
transported to the dentin matrix, as the extracellular matrix is believed to be storehouse for 
the growth factors. Another possibility in line with the work of Russo et al. (1997) may be 
that in the present study, a fraction of FGF-2 is still present in the dentin or in the 
odontoblastic processes on post-natal days 9 and 10. This may exhibit immunoreactivity in 
the dentin matrix. In the later stages, when the mineralization of dentin occurs, this growth 
factor is not expressed.
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Roberts-Clark and Smith (2003) recently measured the concentration of angiogenic factors 
in human dentin matrix. Using an enzyme-linked immunosorbent assay (ELISA) they 
measured the concentration of FGF-2 and other factors in the soluble and insoluble matrix 
fractions isolated from human dentin. It was observed that while high concentrations of 
platelet-derived growth factor (PDGF-AB) and low concentrations of vascular endothelial 
growth factor (VEGF), placenta growth factor (P1GF) and FGF-2 are present in the EDTA- 
soluble matrix fraction, low concentration of epidermal growth factor (EGF) and no FGF-2 
or P1GF was detected in the insoluble matrix fractions.
It is proposed that, in the present work, a definitive presence of FGF-2 in the dentin in these 
two developmental stages can only be defined with further studies using other molecular 
techniques such as in situ hybridization and RT-PCR.
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4.7 FGF-2 and the stratum intermedium
In the present study, the presence of the stratum intermedium was observed only on post­
natal days 9, 10 and 12, in the crown of the maxillary and mandibular molars and the 
incisors. The stratum intermedium, which is a subtle and transient epithelial structure 
associated with the inner dental epithelium, though present at these stages, was not distinct. 
It appears as a layer of stratified epithelial cells (surrounding the ameloblasts proximally). 
In the later stages, as root development progressed apically, this stratified epithelial layer 
disappears. However, while present, no immunolocalization of FGF-2 was observed in the 
stratum intermedium.
Russo et al. (1997) reported the presence of FGF-2 in the stratum intermedium during the 
early and late bell stages (approximately E l8-20) in early mouse tooth morphogenesis. This 
is prior to the stages used in the present study. Russo et al. (1997) also reported that the 
signal for FGF-2 shifts from the epithelium to the mesenchyme in later stages i.e. the late 
bell stage of crown development.
The present study supports the above findings of Russo et al. (1997). It was observed that 
with the progression of root morphogenesis, the expression of FGF-2 disappears in the 
structures of epithelial origin e.g. the stratum intermedium and ameloblasts (with 
progressive disappearance of these structures) and appeared in the structures derived from 
ectomesenchymal cells e.g. odontoblasts.
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4.8 Immunolocalization of FGF-2 in the ameloblasts
Presence of ameloblasts, in the maxillary and mandibular molars and incisors was observed 
on post-natal days 9, 10 and 12. On post-natal day 9, a homogeneous immunoreactivity of 
FGF-2 in the cytoplasm of most of the ameloblasts and in the nuclei of a few ameloblasts 
was noted. The same pattern of expression continued on post-natal day 10 as more 
ameloblasts differentiated apically. Flowever, on post-natal day 12 the signal seemed to 
disappear in most of the cells. In the later stages of development i.e. post-natal days 16, 20 
and 24, ameloblasts were absent. This was probably due to the fact that with elongation in 
the root apically followed by eruption of various teeth in the oral cavity, these epithelial 
derivates i.e. the ameloblasts formed part of the outer layer of the crown that is “peeled” 
away.
Expression of FGF-2 in ameloblasts in the present study is in line with the studies of Cam 
et al. (1992) and Russo et al. (1997) who have reported the presence of FGF-2 in pre- 
ameloblasts and ameloblasts in mouse crown morphogenesis. However, these investigators 
did not comment on the pattern of localization of FGF-2 in the cytoplasm and nucleus. 
Although not a scope of this project, the present study also describes stage specific 
expression of FGF-2 in the cytoplasm and nucleus of the ameloblasts, as occurred in 
different stages of development.
Orr-Urtreger et al. (1991) and Peters et al. (1992) using in situ hybridization techniques 
with local application of the FGF-2 on agarose beads on isolated dental mesenchyme have 
demonstrated the intense expression of FGF receptor-1 (FGFR-1) in ameloblasts and 
odontoblasts and FGF receptor -2  Illb (FGFR-2 Illb) in the ameloblasts, both known to 
bind with FGF-2. Both these studies have suggested that FGF-2 may participate in
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regulation of differentiation and/or secretion of the ameloblasts in early crown 
morphogenesis.
Expression of other members of the FGF family, namely FGF-3, -4, -9 and -10, is also 
known in tooth development (Kettunen and Thesleff, 1998; Kettunen et al., 2000). These 
studies also elucidate that ligand members of the FGF family act as epithelial signals and 
thereby mediate inductive interactions between dental epithelium and mesenchyme during 
successive stages of tooth formation.
It is possible that the early expression of FGF-2 in the epithelial derivates i.e. ameloblasts 
and stratum intermedium followed by progressive expression of FGF-2 in the odontoblasts 
(ectomesenchymal derivatives) of the root in later stages, plays an important role in 
successive development of the tooth. However, a definitive role for FGF-2 in ameloblasts 
could not be determined in the present study.
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CHAPTER FIVE 
5.0 CONCLUSION
Fibroblast growth factor-2 (FGF-2) was localized in the odontoblasts, presumptive 
odontoblasts and cementoblasts of the developing root of both the maxillary and the 
mandibular molars and incisors of the mouse. Also, immunolocalization of FGF-2 
occurred in the presumptive fibroblasts of the pulp and the presumptive osteoblasts, 
cementoblasts and fibroblasts of the periodontal ligament. In addition, 
immunolocalization of FGF-2 also occurred in the ameloblasts from post-natal days 9 to 
12. Although the presence of FGF-2 was also noted in the dentin on post-natal days 9 and 
10, this needs further investigation to support its presence. Localization of FGF-2 
occurred in the cytoplasm and the nucleus as well as in the extracellular matrix of various 
structures as described. Minimal or no background staining was observed in the sections 
incubated with FGF-2.
Reciprocal and sequential epithelio-mesenchymal interactions are said to be important 
regulators of organ/tissue development. These interactions are mediated by growth 
factors such as BMP’s, TGF 13-1 and FGF’s. FGF-2, a ligand member of FGF family of 
growth factors is also considered as a common molecular signal for embryonic 
development.
Immunolocalization of FGF-2 at different morphogenetic stages, spatially and 
temporally, in different structures may indicate its participation in root development. 
Although present at different developmental stages, localization of a specific growth 
factor such as FGF-2, spatially and temporally does not signify a particular function. Its
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role in the mechanisms of cascades of events and interactions requires further 
investigation.
It is believed that if the action of these factors is mimicked and reproduced post- 
developmentally, these molecules may be utilized for the purpose of regeneration 
(Sigurdsson et al., 1995; Murakami et al., 1999).
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APPENDIX
APPENDIX I
Calcium oxalate test for completion of decalcification
Solutions:
(A) Concentrated ammonia (S.G. 0.880)
(B) Saturated aqueous ammonium oxalate
Protocol:
(1) Take approximately 5.0 ml o f used decalcifying fluid and add a small 
piece of litmus paper.
(2) Add strong ammonia drop by drop till the solution is neutral to litmus.
(3) Shake after the addition of each drop.
(4) Add approximately 5.0 ml saturated ammonium oxalate.
(5) Shake well.
(6) Allow to stand for 30 minutes.
Result Interpretation:
(a) If  a precipitate (calcium hydroxide) forms after addition of 
ammonia, a considerable amount of calcium is present. Tissue 
should be kept for a longer period of time to precede further 
decalcification.
(b) If precipitation occurs after the addition of ammonium oxalate, 
less calcium is present. Tissue should be kept for a further 
period of time to precede decalcification.
If the fluid remains clear for 30 minutes, it is safe to assume that decalcification is
complete.
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APPENDIX II
Aminoalkylsilane treatment of slides
Clean slides by leaving them in 10% Extran MA 01 (Merck Darmstadt, Germany) 
overnight.
1. Wash in hot running water for minimum of 2 hours
2. Dry at 60°C in an oven overnight and cool to room temperature.
3. Immerse slides for one minute in a freshly prepared 2% solution of 3- 
aminopropyltriethoxysilane (Sigma Code A 3648) in dry acetone. The capacity of 
this solution is sufficient for the preparation o f 200-250 slides.
4. Give slides two short washes in dry acetone.
5. Give slides short wash in distilled water.
6. Dry at 42°C overnight.
7. Store slides at room temperature.
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APPENDIX III
Haematoxvlin and eosin staining solutions:
(A) Acid Haemalum (Modified Mayer's)
Haematoxylin 1.00 gm
Sodium Iodate 0.20 gm
Potassium Alum 50.00 gm
Citric Acid 1.00 gm
Chloral Hydrate 50.00 gm
Distilled water 1.000 litre
Method
1. Allow haematoxylin, alum and sodium iodate to dissolve overnight.
2. Add chloral hydrate and citric acid and bring to the boil.
3. Continue boiling for 5 minutes.
4. Allow solution to cool down at bench side.
(B) Stock eosin
Eosin 8.00 gm
Erythrosine 2.00 gm
Distilled water 1000 ml
(C) Eosin working solution 
Stock eosin 250.00 ml
Distilled water 750.00 ml
Calcium chloride 20.00 gm
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APPENDIX IV
Phosphate Buffered Saline (PBS) and 0.1% Tween -20
(1) Sodium chloride 16.00 gm
(2) Potassium chloride 0.40 gm
(3) Disodium hydrogen phosphate 2.88 gm
(4) Potassium dihydrogen ortho phosphate 0.48 gm
(5) Distilled water 1600 ml
Method:
(1) Put all four reagents in distilled water together
(2) Mix well on a stir plate
(1) Adjust the pH to 7.4 with hydrochloric acid.
(2) Make up to 2.0 litres with distilled water.
(3) Add 2ml of Tween-20 and shake well.
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APPENDIX V
ImmunoCruz™ staining system (Cat #sc-2051)
Reagents in ImmunoCruz™ staining system
Negative control (normal rabbit IgG) 15 ml
Peroxidase block 15 ml
Serum block (5% normal goat serum) 15 ml
Biotinylated secondary antibody 15 ml
HRP-strept-avidin reagent 15 ml
50X peroxidase substrate 5 ml
5 OX DAB chromogen 5 ml
10X substrate buffer 5 ml
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APPENDIX VI
10 m.M sodium citrate buffer
(4) Add 2.1 gm of citric acid in 1.0 litre of distilled water.
(5) Adjust pH to 6.0 with 2 M sodium hydroxide (Na OH).
Appendices
APPENDIX VII 
HRP substrate mixture
Use reagents from ImmunoCruz™ staining system (Cat #sc-2051) 
Method:
(1) Place 1.6 ml de-ionized water in the substrate-mixing bottle.
(2) Add 5 drops o f the 1 OX substrate buffer.
(3) Add 1 drop of the 50X DAB chromogen.
(4) Add I drop o f the 10X peroxidase substrate.
(5) Mix well on a stir plate.
This mixture should be sufficient for 15 to 20 slides.
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